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ABSTRACT
NUCLEOTIDE-DEPENDENT PREFERENTIAL LOCALIZATION OF
RAS IN MODEL MEMBRANES WITH
LIPID RAFT NANODOMAINS

Anna Shishina, B.Sc., M.Sc.

Marquette University, December 2017

Membrane proteins constitute a third of all proteins in the cell and more than 50%
of drug targets. However, the analysis of membrane proteins has many challenges owing
to their partially hydrophobic surfaces, flexibility and lack of stability.
One example of an essential membrane protein is Ras superfamily. Ras is a small
monomeric GTPase involved in regulation of cell growth, proliferation and
differentiation. Therefore, Ras and its effectors are among the most important targets for
cancer therapy. A detailed knowledge of the processes occurring during signal
propagation via Ras might help to elucidate the mechanisms of the involved signal
cascades.
The preparation of lipid-modified Ras proteins and their study in the presence of
the lipid membrane mimic is the subject of this work. Here we investigate the Ras
interaction with lipids in isolation from a possible modulation by other cellular membrane
proteins. In our study we focus on a property of Ras that it does not act as an ordinary
membrane protein, which stays anchored at the same lipid domain throughout its lifetime.
Instead, Ras is capable of moving between raft and disordered lipid domains during its
functional cycle.
It is suggested that Ras binds to some membrane proteins, and thus changes its
localization. We have demonstrated that Ras molecule directly recognizes lipid domains,
and its binding affinity depends on the activation state of Ras. The results of this work
contribute to the further elucidation of the mechanisms of tumorogenesis and may
provide new starting points for further developments in cancer therapy.
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1. Introduction
1.1

Ras Superfamily Proteins
Among variety of biomolecules, proteins play a crucial role performing a number

of vital cellular functions including: enzymatic catalysis, structural scaffolding, signaling
and transport.
Ras superfamily was first described more than forty years ago and recognized as
oncogenic protein in rats (1). Currently, Ras is one of key targets for cancer treatment
being responsible for 20-30% of human cancers while being a sole cancer driver for
particular cancer types. For example, pancreatic cancer cells have 90% of mutated Ras
genes (2).
Ras studies started with observation that certain sarcoma retroviruses cause
tumors formation in rats. In two types of retroviruses, Harvey and Kirsten discovered the
genes for the corresponding oncoproteins: H-Ras (Harvey) and K-Ras (Kirsten). N-Ras
(neuroblastoma) was discovered in 1983 in human neuroblastoma cells (3). By the
sequence homology Ras proteins belong to the so-called small G-proteins family, which
is a sub-class of G-proteins (4). The Ras superfamily is the most examined and it is
divided into six subfamilies: Ras, Rab, Ran, Rho, Rad und Arf families (Figure 1-1).
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Figure 1-1 Ras superfamily of GTP-binding proteins with their functions

Small G-proteins act as regulators in all important biological functions, such as
transmembrane signal transduction (Ras), cytoskeleton organization (Rho), gene
expression (Ras, Rho), intracellular vesicle transport (Rab, Arf) and microtubule
organization (Ran) (5). Because of the cancer relevance, we focused this study on Ras to
advance understanding the Ras signaling and protein-lipid interactions.

1.1.1

Ras Structure

Proteins in Ras family share a common structural organization. The N-terminal G
domain (c.a. 166 amino acids) binds guanosine nucleotides and has size about 20 kDa. It
contains a six-stranded beta sheets and five alpha helices (Figure 1-2). The N-terminal G
domain is linked with an unstructured C-terminal hypervariable region, HVR, usually
consisted of 22-23 amino acids.
The G domain is responsible for nucleotide binding and contains five G motifs:
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•

G1 motif or P-loop that binds the beta phosphate of GDP and GTP;

•

G2 motif or Switch I, including the Threonine-35 that binds the terminal
phosphate of GTP and the divalent magnesium ion in the active site. T35 makes
no contacts with GDP;

•

G3 motif or Switch II, including the Aspartate-57 and Glutamine-61 residues that
activate a catalytic water molecule for hydrolysis of GTP to GDP;

•

G4 motif providing specific interaction with the guanine base;

•

G5 motif including alanine-146, which is specific for guanine (rather than adenine)
recognition (6).

Figure 1-2 Schematic representation of Ras GTPase. H-Ras G-domain is 166 amino acids long with six
beta sheets (b1-b6) and five helices (a1-a5). The GTP*Mg2+ ligand represented as magenta sticks and a red
sphere, respectively
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The switch motifs (G2 and G3) are flexible and undergo conformational change
upon activation by GTP. This change in the conformation leads to differential affinity to
effectors and constitutes the basic functionality of Ras as a molecular switch.

1.1.2

Molecular Switch

While the hydrolysis of ATP is used as an energy source for metabolic processes
in the cells, GTP appears to be the primary molecule for the regulation of guanine
nucleotide binding proteins (GNBP) including Ras. A universal feature of all GNBP
proteins is the presence of two different conformational states: the active GTP-bound
state and inactive GDP-bound state. Therefore, the GNBPs are often described as
molecular switches (Figure 1-3).

Figure 1-3 Ras conformational switch between active and inactive states is driven by the action of GAP and
GEF factors

An extracellular signal activates GEF that stimulates the dissociation of GDP
from the GDP-bound Ras and binding of GTP, leading to the conformational change of
the switches (effector binding region). The effector-binding affinity of this region
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increases ∼100 fold, effectors are bound and activated, which propagates extracellular
signal into the cell.
The signaling cascade is shut down when the Ras-GTP is converted to Ras GDP
by the action of the GTPase activating protein (GAP). Thus, one cycle of activation and
inactivation achieved. The rate-limiting step of the GDP/GTP exchange reaction is the
dissociation of GDP from the GDP-bound form. This reaction is extremely slow and
therefore stimulated by a regulator, named GEF (guanine nucleotide exchange factor).
GTP cleavage is also intrinsically slow and accelerated by proteins (7).
The oncogenic mutations in Ras interrupt the cycle by the GAP-induced GTPase
activation (8). Thus, unlike normal Ras, mutant proteins remain constitutively in the
active GTP-bound form and continuously transmit signals, which ultimately lead to
uncontrolled cellular growth and division.

1.1.3

Post-Translational Modification

Post-translational modification refers to the further processing of protein after the
ribosomal synthesis as a way to develop the biologically active state. Examples of
modifications are glycosylation, lipidation, acetylation, methylation, hydroxylation, and
phosphorylation (9).
Each type of modification gives proteins distinct membrane properties. In
particular, affinities, lipidation increases the hydrophobicity of a protein and endows it
with affinity for membranes. An example of lipid-modified, membrane-anchored proteins
are the Ras GTPase.

18

Figure 1-4 Types of hydrophobic site chains introduced by post-translational modification of membranebinding proteins

The examples of membrane attachment anchors include:
•

An isoprenoid group contains 15 (in farnesyl, Far) or 20 (in geranylgeranyl,
GerGer) carbon atoms attached to a cysteine residue at the C-terminus via a
thioether linkage. The carboxyl group of the cysteine may also be methylated

•

A palmitic acid is a 16-carbon saturated fatty acid. It is attached to a cysteine
residue via a thioester linkage
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•

A myristic acid is 14-carbon, saturated fatty acid, which is attached to a glycine
residue at the N-terminus via an amide linkage.
Ras proteins are biologically active only when they are located on the inner side

of the plasma membrane. For this purpose, the proteins undergo a series of
posttranslational modifications (10). When Ras does not have these modifications it is
located in the cytosol and is inactive. The part of hypervariable domain responsible for
the membrane connection is the C-terminal CaaX motif, where C is a cysteine, a is
aliphatic amino acid and X is any amino acid. The CaaX is a recognition sequence for
farnesyl or geranyl geranyl transferase (FTase), which adds corresponding modifications
near C-terminus. In case if farnesyl residue is added, farnesylpyrophosphate (FPP) is used
as a source (Figure 1-5). After prenylation, the aaX tripeptide removed by a protease and
the free cysteine esterified by a methyltransferase proteocytosolic
carboxymethyltransferase (pcCMT).
All Ras proteins have farnesylated cysteine methyl ether at their C-terminus.
From this point, further paths of the isoforms run differently: K-Ras4B has a polybasic
stretch near the C-terminus, which induces electrostatic interaction with the positively
charged membrane surface and the other isoforms receive one or more palmitoyl chains
through action of palmitoyltransferase (PalTase). Figure 1-5 illustrates this processing on
the example of the N-Ras protein.

über stabile Verankerung durch vorherige Palmitoylierung der Proteine würde eine
Palmitoyltransferase (PAT) im ER oder Golgi vorliegen. Als möglicher Kandidat für eine
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PAT wurde kürzlich Erf2p identifiziert.[66]

Figure 1-5 Schematic representation of post translational modification of N-Ras protein (11)
Abb. 10 Posttranslationale Modifikationen und Membranlokalisation von K-Ras4B und N-Ras. Abkürzungen:

FPP: Farnesylpyrophosphat, FTase: Farnesyl Transferase, pcCMT: proteocytosolische Carboxymethyltransferase,
SAM: S-Adenosyl-Methionin,
PalCoA: Palmitoyl-Coenzym A, PalTase: Palmitoyltransferase.
1.2
Biological Membranes

Seit einiger Zeit wird die Plasmamembran nicht mehr als gleichförmige
The living cell angesehen,
is surroundedsondern
by a lipid als
membrane,
which are semi-permeable
Lipiddoppelschicht
ein komplexes
Mosaik einzelner
Mikrodomänen.
Lipid rafts
sind solche
Domänen
in der Zellmembran,
diethe
sich durch
barriers
with the primary
function
of separating
the intracellular
contents and
eine veränderte Lipid- und Protein-Zusammensetzung von der restlichen Membran
environment. The lipid membrane is involved in containment and separation, signal
unterscheiden. Sie sind einerseits fluid, andererseits aber durch ihre laterale
transmission, as well as the transport of ions and molecules.
22
1.2.1

Allgemeiner Teil

Membrane Lipids: Structure and Properties

The lipids are a major component of biological membranes. Membrane lipids are
very diverse: any specific membrane may comprise more than one hundred different
types of lipid molecules.
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1.2.1.1 Types of Membrane Lipids

Phospholipids - is the most abundant class of lipids in membranes. A molecule
has four components: fatty acids, a glycerol moiety to which the fatty acids are attached,
a phosphate, and a polar component (Figure 1-6). One of the hydroxyl groups of glycerol
is associated with a polar group containing phosphate, and the other two - with
hydrophobic residues. The fatty acid components provide hydrophobic properties,
whereas the remainder of the molecule is hydrophilic facing the solution. In nature,
different fatty acids (long-chain carboxylic acids) are bound to the glycerol via the ester
bond. The alkyl radicals always have an even chain length due to specificity of the
biosynthetic pathway. In addition to their alkyl chain length, the lipids also differ in the
number of double bonds in the alkyl group (unsaturated fatty acids). The presence of
double bonds reduces the melting temperature of the lipids, which allows the membrane
to remain fluid at normal conditions. The alkyl chains are linked to the glycerol via
relatively unstable ester bonds. In nature, the bond can be easily hydrolyzed of re-formed.
In this way, cells are able to adapt their lipid membranes to the changing conditions of
their environment as well as during their life cycle.
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Figure 1-6 Schematic structure of a phospholipid

Based on the type of the platform lipids are classified in two main classes:
phosphispingolipids (based on sphingosine) and phosphoglycerides (based on glycerol).
Phospholipids derived from glycerol are called phosphoglycerides (Figure 1-7).

Figure 1-7 Structures of different phosphoglycerides

Phosphatidic acid is the simplest representative of phosphoglycerides and a
precursor in the biosynthesis of other phospholipids. Phosphatidylcholine (PC) is a major
cell membrane component of higher plants and animals. A bacterial cell does not contain
PC. Phosphatidylcholine also plays a significant role in membrane-mediated cell
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signaling. Phosphatidylethanolamine is one of the main components of the bacterial cells
membranes. Phosphatidylserine plays a key role in cell cycle signaling, and works as a
regulator of the activity of several membrane-bound enzymes. Phosphatidylinositol is a
minor component on the cytosolic side of eukaryotic cell membranes.
Phosphatidylglycerol is the major component of bacterial membranes (70% total)
(12). Glycolipids are lipids containing carbohydrates. Their role is to provide energy and
serve as markers for cellular recognition. Sterols are neutral lipids, which are present in
plants, animals and bacteria. Most abundant example of sterols is cholesterol (Figure 1-8).

Figure 1-8 Structure of cholesterol

Cholesterol is an essential structural component of animal membranes and is
required to maintain both membrane structural integrity and fluidity. In addition, it serves
as a precursor for the biosynthesis of steroid hormones, bile acids, and vitamins.
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1.2.1.2 Lipid Phases

In the presence of water, lipids self-assemble in a form of lipid bilayers.
Depending on the lipid type, the temperature and the water content, phospholipids can
form different phases. At low temperatures, lipids have chains ordered and organized into
the membrane plane in a hexagonal lattice. Above a characteristic temperature that order
is disrupted and the lipids transition into a more fluid phase. The phase below this
melting point (Tm) referred as gel phase and the one above the melting point as a fluid or
liquid crystalline phase (13). The melting temperatures of saturated chains of saturated
C18-phospholipids are well above room temperature while in natural membranes with
unsaturated fatty acids melting temperatures may be less than 0°C.
Solid-ordered phase is also referred to as a gel phase (Lβ). In the Lβ phase, the
hydrocarbons are stiff, fully extended and regularly oriented on a two-dimensional lattice.
They can rotate slowly (on a time scale of 100 ns) in this phase along their longitudinal
axis, but show almost no lateral diffusion. Above a certain temperature or water content,
the hydrocarbons produce a transition from the Lβ to a liquid phase, the Lα phase (14).
This phase is characterized by a high lateral diffusion of the lipids and a lower degree of
order of the hydrocarbon chains. Therefore, it is also referred to as a liquid-disordered
(Ld) phase.
A particular case of the lipid phases in biomembranes is the liquid-ordered (Lo)
phase (raft phase). On the one hand, this is characterized by a high degree of order of the
hydrocarbon chains (similar to the Lβ phase); on the other hand the lipids show a high
lateral diffusion (similar to the Ld phase) within the Lo phase (15). In cellular membranes
cholesterol is tightly packed in the Lo phase between the carbohydrate chains of the
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glycerophospho- and (glyco-) sphingolipids, forcing them to a higher order (16). In
model membranes, this interaction can lead to microscopically distinguishable Ld / Lo
phases. The Lo phase is rich in saturated glycerophospholipids or sphingolipids and
cholesterol in such membranes, whereas the Ld phase is rich in unsaturated
glycerophospholipids.

1.2.2

The Structure of Biological Membranes

1.2.2.1 The Fluid Mosaic Model of Membrane Structure

The present idea of the structure of cell membranes has been proposed by Singer
and Nicolson in 1972 (17). They presented the fluid mosaic model, which resulted from
the idea of a moving lipid bilayer. The lipids with hydrophobic hydrocarbon chains and
hydrophilic head groups accumulate through hydrophobic interactions of the alkyl chains
and form the lamellar double-layer structure by self-organization. Within the individual
lipid layers, the lipids can move freely and the membrane thus behaves as a twodimensional liquid. Movement of the lipids from one membrane sheet into another, the
so-called flip-flop, is possible; but the kinetics of this process is slow. The integral
membrane proteins (e.g., receptors and ion channels) penetrate the bilayer and are
laterally mobile within the membrane. These membrane proteins form a link between the
cell interior and the environment.
The membrane bilayer itself has a total thickness of about 40-50 Å. One layer
consists of 15 Å-length alkyl chains and 5 Å hydrophilic head groups (Figure 1-9).
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~0.5 nm
~1.8 nm

~5 nm

~1.8 nm
~0.5 nm
Figure 1-9 Dimensions of the lipid bilayer

1.2.2.2 Asymmetry in Membranes

Most cell membranes are asymmetric, i.e. the outer and inner side of the
membrane differs in composition. This asymmetry involves both protein and lipid
components:
•

Asymmetry of proteins in biological membranes determined by their biogenesis

•

Lipid asymmetry is a relative: usually the outer and the inner monolayer
composed of same lipid types, but the concentration of lipids in each side varies.
Transmembrane distribution of lipids in membranes is defined by their biogenesis,

and influenced by the outer media and inner cell conditions.

1.2.2.3 Subdomains in Membranes

After discovery of the liquid ordered phase, the fluid mosaic model of the
membrane was revised (18). Rafts and caveolae domains have a capacity to selectively
include or exclude proteins and thus alter protein/protein or protein/lipid guided
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interactions (Figure 1-10). The size of the microdomains is different depending on cell
type ranging is from 50 to 700 nm (19).

Intracellular space

Raft-associated
protein

Lipid raft
Non-raft membrane

HO

HO

HO

HO

HO

HO

Disordered phase (Ld)

Ordered phase (Lo)

Cholesterol

Extracellular space
Figure 1-10 Schematic representation of lipid raft and proteins in a membrane

Lipid rafts and caveolae are specialized regions of the membrane thought to serve
important biological functions. In particular, they provide a scaffold for organizing
signaling protein complexes (20). The lipid composition of rafts and caveolae provides a
unique membrane microenvironment rich in cholesterol and sphingomyelin, which create
a liquid-ordered (Lo) phase domain promoting aggregation of signaling components.
Presently, membrane rafts are defined as combinations of glycosphingolipids and
ordered assemblies of specific proteins, in which the metastable resting state activated by
specific lipid–lipid, protein–lipid, and protein–protein interactions (21). It has been
proposed that lipid rafts serve to collect proteins when needed for signal transduction.
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1.2.2.4 Lipid Raft Dynamics

There are a number of challenges associated with studying of lipid rafts in living
cells. Natural lipid rafts are quite small ranging from 10–200 nm, which is below the
resolution limit of an optical microscope. Thus, lipid rafts are difficult to visualize and
observe in vivo and in vitro. Using advanced laboratory methods and imaging techniques,
such as fluorescence quenching, fluorescence microscopy, electron microscopy, X-ray
diffraction and small-angle neutron scattering lipid rafts were detected in living cellular
membranes (22). It became evident that the lipid rafts are dynamic and do not remain
intact for a long time.
It is believed that formation of membrane domains is induced by molecular
interactions between proteins and lipids. One remarkable example of this phenomenon is
an induction of raft-like domains by a NAP-22 protein.
NAP-22 is a myristoylated protein found in neurons (23). From fluorescence
microscopy studies, it is known that NAP-22 partitions into low-density fraction of
neuronal membranes, suggesting it’s affinity to rafts. It specifically interacts only with
cholesterol-containing liposomes (24).
Atomic force microscopy (AFM) is one of a few imaging techniques with
sufficient resolution to observe rafts. A tremendous advantage over electron microscopy
is its temperature and physiological aqueous conditions. Because of the different packing
of the Lo and Ld phases, these membrane domains have different thicknesses and
detectable by AFM. Figure 1-11 schematically represents a lipid rafts protruding from a
bilayer. On the right is the AFM image of protein associated with lipid rafts (25). Red
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“islands” is a lipid raft emerging from the black background (disordered bilayer) and the
tall peaks are protein molecules.

Lipid raft

HO

HO

HO

HO

HO

HO

Ordered phase (Lo)

Figure 1-11 Lipid bilayer with rafts (red islands) and associated protein (peaks) (26)

Epand and colleagues studied specificity for cholesterol binding properties of
NAP-22 by differential scanning calorimetry (DSC) and atomic force microscopy (AFM)
(27). AFM revealed a significant change in the surface of a supported bilayer upon
addition of NAP-22. Prior to the addition of the protein, the bilayer looked like a smooth
structure with uniform thickness. Addition of NAP-22 resulted in the rapid formation of
localized raised bilayer domains (Figure 1-12).

Figure 1-12 AFM height images of bilayer with cholesterol in the presence of NAP-22 taken 10 (A), 15 (B),
and 20 min (C) after the addition of protein (27)
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Remarkably, addition of the protein solution caused a rearrangement of the lipid
bilayer without any destruction. These results clearly confirmed that NAP-22 induces the
formation of cholesterol-rich domains in lipid membranes, which may be revealing
organizing role of integral membrane proteins in a lateral lipid bilayer structure.

1.2.3

Model Lipid Bilayers

In contrast to the natural biological membranes, the term “model membrane” is
intended to describe artificial lipid bilayers, which help to understand and imitate the
structure, properties and functions of membranes. To date, model membranes developed
for the construction of membrane models including black lipid membranes (BLM),
supported bilayers, lipid bicelles, lipid vesicles and most recent development of
phospholipid bilayer nanodiscs (Figure 1-13) (28), (29), (30). Some of these models will
be discussed below.
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A

B

C

D

Figure 1-13 Examples of lipid assemblies: (A) supported lipid bilayer, (B) lipid bicelle, (C) lipid vesicle, (D)
nanodisc. Drawing not to scale

1.2.3.1 Lipid Structures in Water. LUV and MLV

The lipids are amphiphilic substances, which are poorly soluble in both polar and
nonpolar solvents. The presence of both hydrophilic and hydrophobic parts in the lipid
molecule drives these compounds to form aggregates in the presence of water. The most
energetically favorable state of a hydrated lipid is a monolayer at the interface between
polar and nonpolar environment or a bilayer with two hydrophilic surfaces and
hydrophobic interior (Figure 1-13).
The driving force behind of the lipid aggregates formation in aqueous media is
hydrophobic effect (31). The basic principle is that hydrocarbon chains of fatty acids
distort hydrogen bonds in water and, therefore, tend to self-associate. On the other hand,
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lipid polar domains tend to interact with water and therefore stable in an aqueous
environment (32).
The final shape of lipid structures in solution is defined not only by
thermodynamic parameters but also by the structure of lipid molecules. There are three
possible types of supramolecular structural organizations (phases) of lipids in aqueous
media (Figure 1-14).
Depending on the volume ratio of the head groups and non-polar chains, all lipids
divided into three groups: inverted cones, cylinders and cones. Repulsive forces between
close head groups and tendency of fatty acids to self-associate defines the overall
structure. Lipids with relatively close volumes of polar and non-polar parts tend to a form
bilayer or lamellar structure, whereas other types of lipids form nonlamellar micellar and
cubic phases. This ability of lipids referred to as lipid polymorphism (33).
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Cylindrical

Inverted cone

Conical
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Figure 1-14 Lipid polymorphism: depending on the relative sizes of hydrophobic and hydrophilic parts
lipids can form different lipid structures

If the lipids are placed in an aqueous environment, their molecules form
aggregates - micelles, in which the polar heads of the lipids facing outward and nonpolar
hydrocarbon chains hidden inside. In nonpolar medium micelles turned inside out, to
form inverted micelles (Figure 1-15).

34

Inverse micelle

Typical micelle

H2 O

H 2O

H 2O

O
H2

H2O

O
H2

2

HO

Figure 1-15 Lipid micelles in water (typical micelle) and non-polar solvents (inverse micelle)

When the concentration of lipids in water increases, the micelles eventually stick
together and form a bilayer. Natural lipids have extremely low critical micelle
concentration (CMC): 10-10 M. The thickness of the lipid bilayer is determined by the
length of the hydrocarbon chains and usually around 4-5 nm, but it depends on the
packing density of the lipid molecules in the bilayer.
With further increase of lipid concentration bilayers stratifying each other to form
multilamellar lipid structures. Gentle stirring induces the formation of spherical particles
– liposomes (Figure 1-16).

35

A

B
Water

Water

Lipid bilayer

Figure 1-16 Schematic structure of liposomes: (A) multilamellar vesicles, MLV; (B) small or large
unilamellar vesicles, SUV and LUV

Liposomes, typically, consist of a series of bilayers separated by water; the
distance between the layers is 15-20 Å, liposome diameter range is 5-50 microns. Such
liposomes, consisting of numerous bilayers, are known as multilamellar vesicles (MLVs).
By gentle swirling of MLV, individual spheres are able to detach to form large
unilamellar vesicles (LUVs). Small unilamellar liposomes (SUVs) can be obtained by
ultra-sonication of MLVs. Another technique, which allows obtaining LUVs of the
uniform size, is extrusion. In this method the lipid mixture is passed through the
membrane of a specific pore size, which forces MLV to redistribute and form smaller
LUV (34).

1.2.3.2 Supported Lipid Bilayers (SLB)

Due to their spherical geometry of LUVs and MLVs, only very few
characterization methods and measurement methods are available. The range of different
analytical methods is significantly greater on planar substrate-supported systems, in
particular if this is a metallic or semiconducting substrate or an optically transparent
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substrate. By means of Langmuir-Blodgett transfer (LB transfer) it is possible to transfer
a lipid monolayer to hydrophilic substrates such as glass or surface-oxidized silicon(35).
The second molecular layer can subsequently be applied, for example, via LangmuirSchäfer transfer (36). For this purpose, the substrate with the first monolayer is immersed
horizontally into the lipid monolayer pre-oriented at the water / air interface. A further
method of completing the membrane is vesicle fusion (37). In this method, the first
monolayer is also applied by an LB transfer, and the substrate is then transferred to a
freshly prepared liposomal solution (Figure 1-17). The second monolayer then forms
spontaneously. With this method, lipid bilayers can also be obtained directly, without the
previous LB transfer of a monolayer.

Bulk water

Thin water layer
Solid support
Figure 1-17 Supported lipid membrane on thin water film

The supported lipid bilayers do not directly contact the hydrophilic substrate.
Instead, a very thin water pad separates a hydrophilic head groups from the substrate
surface. The resulting water reservoir is very thin approx. 5 - 20 Å allowing allows lateral
diffusion of the lipids in the lower membrane half (38), (39). Supported lipid bilayers
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were successfully used for incorporation and analysis of small membrane proteins (40),
(41).

1.2.3.3 Nanodiscs

Recently, another type of membrane mimics received a wide usage – lipid
nanodiscs. The nanodiscs consist of a piece of bilayer surrounded by an amphipathic
protein belt (MSP) shielding hydrophilic side of a bilayer from aqueous solution (42). For
the reconstitution of different sized discs specifically tailored for different membrane
proteins (43), (44).

Figure 1-18 Structure of Apo-A1 used for nanodisc preparation
MSPs are alpha helical proteins derived from the apolipoprotein A-1 (ApoA1),
which is the primary component of high-density lipoprotein particles (43) (Figure 1-18).
A typical MSP1 is a truncated Apo-A1 fused to an N-terminal histidine tag by a linker
containing a protease site for easy removal of the His tag. By changing the number of
amphipathic helices of Apo-A1, the MSP sequence can be varied which allows for the
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preparation of nanodiscs with different sizes, from 5 to 12 nm (45), (46). Formation of
nanodiscs is spontaneous self-assembly process initiated by detergent removal from a
lipid solution. Nano discs are more stable than lipid vesicles at low concentrations, which
makes them a particularly useful for structural studies of membrane proteins (47), (48).

1.3

Bioorganic Synthesis of Ras Homologs
Synthetic peptides and proteins are among the most important tools in chemical

and biomedical research areas. Introduction of solid-phase peptide synthesis by
Merrifield in 1963, who synthesized the nonapeptide bradykinin within a few days
revolutionized the field (49). This technique allowed for production of proteins and
peptides, which cannot be expressed in cells or difficult to isolate. The progress in solid
state peptide synthesis continues today with development of new resins, protective groups
and coupling reagents for production of functionalized.

1.3.1

Principles of Solid Phase Synthesis

The solid phase synthesis uses the polymeric reactive carrier, which
functionalized to attach other substrates (Figure 1-19). Because of the presence of inert
solid support, large excess of reactants may be used, driving reactions to completion. The
reagent excess is easily removed by washing the resin with an appropriate solvent. In the
beginning the substrates were applied directly to the polystyrene supports, but later the
linker systems between the polystyrene resin and the functional group were introduced,
which allows cleaving the final product off the resin under a variety of conditions (50).
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Figure 1-19 Principle of solid phase synthesis of peptides (X = protecting group; A=amino acid)

The linker is bifunctional: one end of the linker is used to attach the molecule to
be synthesized; this bond should be easily cleaved under special conditions (e.g., silyl
ethers, esters). The other part is connected to the polymeric matrix via a stable bond (for
example ether, amide).
Some of available linkers are in fact, based on protective groups and therefore
inherit a rough classification based on their cleavage conditions (Figure 1-20).
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Figure 1-20 Types of linkers used in solid-phase synthesis

In order to obtain a peptide on a solid phase, there is a need for so-called coupling
agents in order to increase the reactivity of molecules to be coupled.

1.3.2

Synthesis of Lipidated Peptides

The synthesis of lipidated peptides is challenging because of the presence of
multiple active groups and labile ester bonds in proteins. Introduction of hydrophobic
side chains leads to a completely different behavior of lipopeptides in solution compared
to non-lipidated peptides. Therefore, ether precipitation that is normally used for the
purification of peptides is useless here. In addition, instability of the lipid groups leads to
other limitations. For example, thioester linkage is not stable towards nucleophiles, and
isoprenyl residues are sensitive to acids and unstable to reductive conditions (Figure
1-21). Furthermore, in the case of Ras proteins N-terminal carboxyl group should have
methyl ester form.
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Figure 1-21 Acid-base sensitivity of lipid groups in Ras lipopeptides (X=protection group)

There are two strategies for synthesis of modified peptides: the modification can
be introduced either by coupling modules or by subsequent modification of the
selectively deprotected peptide. First strategy implies to use pre-lipidated building blocks
that are coupled during the synthesis on the solid phase. Second approach utilizes
unmodified peptide that receives palmitoyl and the farnesyl residues on the solid phase
(51), (52).

1.3.3

Modular Approach for Semi-Synthetic Ras Proteins

The modular approach for production of semi-synthetic proteins combines
organic synthesis of lipopeptides and expression of the remaining part of Ras-protein. A
great advantage of such approach is that one can introduce novel properties (e.g.,
fluorescent labels) without affecting the protein core. Effective ligation strategy is a key
for producing peptide and protein conjugate faithfully mimicking natural lipoproteins.
There are three possibilities to generate artificial lipopeptide-protein conjugates with Ras:
in vivo farnesylation, maleimidocaproyl linkage and native chemical ligation (Figure
1-22).
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Figure 1-22 Strategies for the synthesis of artificial protein conjugates

First, modified lipids can be introduced via enzymes. Thus, Ras proteins can be
modified in vitro using the farnesyltransferase (53). However, this is not a general
approach for the synthesis of lipoproteins, for example, the palmitoyl residue cannot be
introduced enzymatically. In a second approach, synthesized lipopeptides are attached to
truncated proteins with the aid of a maleimidocaproyl (MIC)-linkers. The third approach
uses the principle of native chemical ligation, where lipopeptides coupled with constructs
obtained from the overexpressed protein. The latter two methods will be discussed in the
following subsections.

1.3.4

Coupling of Lipopeptides via the MIC-Linker

In this method, a terminal maleimidocaproyl group is coupled to the lipopeptide.
MIC is a thiol-specific electrophilic group that reacts selectively with the N-terminal thiol
of cysteine of the truncated Ras protein (Scheme 1-1) (54), (55). The reaction performed
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in a buffer system; the reaction products are purified by detergent extraction and
chromatography. By this method, a number of Ras proteins with various lipidation motifs
were synthesized in multi-milligram quantities and high purity (56).
The main disadvantage of this method is that the bond between protein and
peptide is non-native introducing an artificial spacer of ∼ 2 Å. However, protein-peptide
conjugates with such unnatural linker were shown to preserve their biological function as
a molecular switch in signal transduction in vivo (56, 57).

Scheme 1-1 Creation of full-length lipidated Ras protein through MIC-ligation

1.3.5

Native Chemical Ligation

Along with the artificial MIC ligation, a completely natural, ideally suited to
protein synthesis technique called native chemical ligation was developed in the Kent
laboratory in 1994 (58). This method takes advantages of biochemical reactions involving
interactions of carboxyl and thiol groups and S,N-acyl rearrangement.
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1.3.5.1 Principle of Native Chemical Ligation

This strategy involves the chemoselective reaction that occurs between a peptide
containing an N-terminal cysteine residue and a second peptide containing thioester
group (Figure 1-23) (59).
The initial transthioesterification reaction is followed by a spontaneous
intramolecular S,N-acyl shift to generate amide bond between two fragments.

Figure 1-23 Schematic principle of native chemical ligation (11)

The only requirement of this technique is that the peptide fragments contains the
necessary reactive groups, either cysteine or thioester.
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1.3.5.2 Protein Splicing and Expressed Protein Ligation

In analogy with well-known process of mRNA splicing, in which introns are
removed and exons are joined, another form of proteins post-translational modification
was discovered in 1990, called the protein-splicing (60), (61). It is an intramolecular
reaction of a particular protein in which an internal protein segment is released and Cterminus and N-terminus can be joined. Chemical ligation of this kind using recombinant
C-terminal thioesters known as expressed protein ligation.
The Expressed protein ligation (EPL) or Intein-mediated Protein Ligation (IPL) is
broadly applicable in vitro method for the chemoselective addition of modified peptides
to recombinant proteins (62). This technology enables to introduce a number of
modifications and unnatural amino acids into final proteins.
Based on the studies of the mechanism of protein splicing New England Biolabs
developed a novel protein purification system that allows recombinant proteins to be
purified without affinity tag - IMPACT (Intein-Mediated Purification with an Affinity
Chitin-binding Tag). The IMPACT permits expression of target proteins carrying an
intein-chitin binding domain (intein-CBD) tag for one-step purification using a chitin
resin (Figure 1-24) (63). The advantages of this method were used for in vitro synthesis
of two Ras-type proteins (64).
The Ras moiety was expressed with an intein and with a chitin-binding domain
for easy purification (Figure 1-24). Then by analogy with protein splicing, intein cleavage
induced by addition of mercaptoethanesulfonic acid sodium salt (MESNA) (65). The
resulting protein, activated via a thioester, was attacked in a native chemical ligation
reaction by the thiol group of the N-terminal cysteine of the lipidated peptide. Finally,
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spontaneous S,N-acyl rearrangement generates the native peptide bond between the
protein and peptide.

Figure 1-24 Schematic principle of expressed protein ligation (11)

Activity of the obtained semisynthetic H-Ras/K-Ras lipoproteins was confirmed
via an interaction assay with the catalytic domain of the guanine-nucleotide-exchange
factor SOS (66).

1.4

Semisynthetic Ras as a Tool in Biology

1.4.1

Interaction of Lipidated Ras Peptides with Membrane Models

Understanding of behaviour of lipid-modified protein in a membrane requires
knowledge of contributions from the lipidated peptide. The modular synthetic approach
provides an ability to incorporate various labels (fluorescent, EPR, etc.) almost in any
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position of lipidated peptide allowing application of NMR, FTIR and small angle neutron
diffraction spectroscopy among other techniques.
Huster and co-workers characterized the dynamic distribution of the simplest
system - doubly lipidated N-Ras heptapeptide (Figure 1-25) by Fourier-transform infrared,
solid-state NMR spectroscopy, and neutron diffraction (67).

Figure 1-25 Double lipidated N-Ras heptapeptide (67)

The neutron scattering study revealed complete insertion of lipopeptide anchors
into the hydrophobic matrix of the membrane. Hydrophobic side chains of leucine,
cysteine and methionine delivered additional contributions to membrane incorporation,
while the peptide backbone was located in the interphase between lipid and buffer. These
conclusions were supported by FTIR measurements as phase transition temperatures of
lipid and peptide were at exactly the same temperature (67). The order parameters
calculated separately for peptide and lipid chains revealed that peptide acyl chains are
inserted with much lower order parameters compared to the lipid acyl chains: the longer
16:0 peptide anchors slightly shrink to match the length of the phospholipid 14:0 chains
(Figure 1-26).
Vogel and used 2H NMR to explore the mechanism of insertion of lipidated Ras
into membranes. The lipid chains revealed large order parameters suggesting that the
lipid modifications are highly dynamic and flexible in the membrane (68).
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Figure 1-26 The membrane insertion of the lipid-modified peptide (68)

Tagging proteins with fluorescent probes provides a tool to study them by
microscopy and fluorescence techniques, such as Förster resonance energy transfer,
fluorescence correlation spectroscopy and fluorescence polarization.
A study by Janosch and coworkers represents a preliminary data collected for
lipidated peptides bearing fluorescent dyes (69). The group used two-photon excitation
fluorescence spectroscopy on giant unilamellar vesicles (GUVs) with incorporated
BODIPY–labeled peptide. N-Rh-DPPE lipid was used as a marker of the Ld phase.
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Figure 1-27 Two-photon excitation fluorescence intensity images of GUV with incorporated BODIPYlabeled peptide (69)

Addition of the fluorescently labeled Ras peptide to the GUV led to a phase
separation, which was explained by the high affinity of the lipidated peptide to a liquidordered environment (Figure 1-27). The size of peptide-containing domains decreased
upon decreasing temperature and peptide aggregation occurred at low temperature.
Authors found difficulty to explain the clustering of lipopeptides. The two
possible reasons are the tendency of lipid anchors to self-aggregation or the fact that the
BODIPY molecules form dimers, which prevail at low temperatures and higher
concentrations.
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1.4.2

Studies of Full-Length Lipidated Ras Proteins

The lipid modification of membrane-associated proteins determines the
localization in rafts domains of the plasma membrane. Variety of G-proteins, thought to
be localized in lipid rafts (70). The presence of myristoyl or palmitoyl also leads to a
preferred rafts localization, as was found for α-subunits of heterotrimeric G proteins (71).
The insertion of saturated lipid anchor in the tightly packed lipid rafts structures appears
to be energetically favored. However, cholesterol-modified proteins, such as
transmembrane proteins show enrichment in rafts structures. In that case, probably amino
acids near the transmembrane helix play a critical role (72). Prenylated proteins, such as
proteins with a farnesyl or geranyl-geranyl anchors found outside of rafts domains (73).
The storage of bulky, branched structure of unsaturated isoprenyl chains is energetically
unflavored in tightly packed rafts.
A number of studies were done to investigate the structural dynamics of
membrane association of full-length lipidated Ras proteins. However, only a few
techniques are applicable to these studies. For instance, X-ray crystallography methods
are not applicable due to poor solubility of lipidated protein. Solution NMR also fails
because the samples are too large to tumble with a short correlation time, which gives
very broad signals. However, magic-angle spinning (MAS) NMR was successfully
applied to those systems (74).
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1.4.2.1 NMR Studies

Recently, Huster et al. showed that MAS NMR of bilayer bound lipopeptides
provide ability to determine a structural model of semi-selectively labeled N-Ras protein
bound to DMPC membranes (75). The obtained chemical shifts provided the input
parameters for the structural calculations in program package TALOS (76). TALOS is a
database program, which contains chemical shift information from proteins of the known
X-ray structure. On this basis, the backbone torsion angles may be calculated from the
structure and sequence similarities, which gave the first model of full-length lipidated NRas protein inserted in DMPC (Figure 1-28) in complete agreement with previous FTIR
study (67).

Figure 1-28 Structural model of the membrane-bound C terminus of lipid modified N-Ras protein (75)
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1.4.2.2 IRRAS Study of Lipid–Protein Interaction

To reveal how different Ras isoforms interacts with lipid membrane a number of
experiments were performed, with lipid monolayers using infrared reflection absorption
spectroscopy (IRRAS) (77, 78) as well as X-ray diffraction (79).
Among a wide variety of membrane models lipid monolayers at the air/water
interface (Langmuir films) are the simplest experimental models for biophysical studies
of lipid-protein interactions. They provide several practical advantages from an
experimental viewpoint: aqueous environment with conditions closed to the nature ones,
easily controlled composition, temperature, pH etc., small quantities are required for
experiments.
In the mid 1980’s Dluhy and colleagues showed that IR spectroscopy may be
applied to the lipid films with acquiring molecular structure information (80). The
technique was called IR infrared reflection-absorption spectroscopy (IRRAS). It is based
on the phenomenon that when mid-IR radiation strikes monolayers films, and around 6%
of the light is reflected from the molecular constituents of the surface. Depending on
optical properties of the irradiated interface, it is possible to get a set of IRRAS intensities
and determine the orientation of ordered structural elements (e.g., lipid chains, protein
secondary structures, etc.) (81).
Meister et al. used this technique to access the influence of Ras lipidation motif to
membrane interaction. Group examined two variations of protein: native farnesylated and
hexadecylated (HD/Far-N-Ras) and a doubly-hexadecylated (HD/HD-N-Ras) (Figure
1-29) (77, 78). Langmuir monolayers with lipid composition POPC/BSM/Chol (2:1:1)
were used as a model of rafts.
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Figure 1-29 Structures of Ras constructs (77)

The process of fusing constructs with monolayer was investigated upon changing
lateral pressure. It was found that the insertion of HD/Far Ras takes place only at low
lateral pressure of 10 mN/m, whereas HD/HD N-Ras inserted at higher pressure (30
mN/m). Upon elevated pressure farnesylated/hexadecylated protein was desorbed from
the lipid, whereas the doubly hexadecylated protein remains incorporated, indicating a
higher affinity. These results confirmed an idea that short unsaturated had lower affinity
toward liquid-ordered phases. Authors also concluded that farnesylation alone is
insufficient for anchoring the protein in the plasma membrane (82).

1.4.2.3 Preferential Localization of Ras Isoforms

The involvement of the membrane microdomains domains to Ras-dependent
signaling has been investigated in number of publication discussed further. Different
studies produced somewhat controversial results about sub membrane localization for
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different Ras isoforms. Current view is that farnesylated only K-Ras function outside of
rafts, whereas palmitoylated H-Ras and N-Ras localized in raft domains (Figure 1-30).

Figure 1-30 Membrane localization of Ras isoforms (82)

The explanation is that long chains of saturated fatty acids, such as palmitoyl, fit
well into the ordered lipid structure of rafts whereas the kinked structure of prenyl
moieties disfavors raft localization (73).
Prior et al. in their studies postulated that H-Ras in the GDP-bound state localized
in lipid rafts, whereas GTP-state predominantly found outside of rafts structures. On the
contrast, K-Ras protein localized predominantly in non-rafts fractions regardless of the
bound nucleotide (83).
In addition to biochemical studies, there is biophysical evidence of localization of
Ras proteins in distinct lipid domains. In electron microscopic studies on cell membranes,
the inactive H-Ras distributed between rafts domains and cholesterol-independent
microdomains was shown, while K-Ras and H-Ras predominantly localized in
cholesterol-enriched domains (19). In fluorescence recovery after photo bleaching (FRAP)
experiments it was shown that H-Ras, in contrast to K-Ras, is localized in rafts structures,
while the mutants H-RasG12V and K-RasG12V associate with cholesterol domains (84).
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In the last few years, researches received completely controversial results
regarding Ras isoforms localization. Thus, Alexander Vogel’s group investigated
partitioning of N-Ras between liquid ordered and liquid disordered phases of model
membranes (85). Several lipid mixtures composed of cholesterol, saturated, and
unsaturated phospholipids were used to create lipid raft model systems:
•

PSM/POPC/Chol – mixture with two coexisting phases. The presence palmitoylsphingomyelin (PSM), which is associated with the Lo phase, gives ability to
mimic natural rafts. The POPC (1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine) is enriched in the Ld phase;

•

DPPC/POPC/Chol - PSM was replaced by another saturated lipid DPPC (1,2dipalmitoyl-sn-glycero3-phosphocholine).
Interactions of N-Ras solution with model systems were visualized by Atomic

Force Microscopy (AFM). In AFM a tiny cantilever with a sharp tip is scanned across a
surface (Figure 1-31) (86). The interaction between the surface and the tip cause the
cantilever to bend and the bending is monitored using a laser beam. In this way
nanometer changes in height can be measured and used to generate a three-dimensional
image of surface.
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Figure 1-31 Schematic principle of atomic force microscopy (87)

Because of the different properties of the Lo and Ld phases membrane domains
has different height they detectable by AFM. It also works in aqueous conditions
necessary for natural lipids behavior and became the widely used method for
visualization of proteins raft-complexes. Figure 1-32 shows the corresponding AFM
images of N-Ras incorporated in a mixture that comprises Ld and Lo domains.

Figure 1-32 AFM image of N-Ras in GUV particles and concomitant section profile of the AFM image (88)

The results of study were in complete disagreement with the theoretical
predictions. The proteins was excluded from both Lo and Ld domains and distributed on
the boundary of phases (Figure 1-33) regardless of lipid composition.
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Figure 1-33 AFM images of lipid bilayers before (upper images) and after (lower images) addition of NRas (85)

These results demonstrated that membrane-partitioning behavior of Ras proteins
is a very complex and may be influenced by a number of factors. Protein association with
lipid micro domains was also influenced by membrane composition. One example of this
correlation was described by Nicolini et al (88). BODIPY labeled and completely
lipidated (hexadecylated and farnesylated) N-Ras protein incorporated into GUV (Figure
1-34) was observed by two-photon excitation fluorescence. The results similar to those
one with lipidated peptide were obtained: protein binds preferentially to the liquiddisordered domains.
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Figure 1-34 BODIPY-labeled fully lipidated N-Ras protein (88)

By use of image analysis, the partitioning of the lipidated protein in the various
domains was analyzed. The final AFM results indicated that N-Ras spontaneously inserts
into raft mixtures and preferentially into liquid-disordered domains, with a large
contribution of the lipidated peptide residing in the boundary.
Werkmüller et al. used time resolved fluorescence anisotropy to study the
mobility of full-length K-Ras4B with a BODIPY label in the protein core upon binding
with a membrane (89). Binding to various model-membrane systems, including purefluid, liquid-ordered and (Lo/Ld) heterogeneous charged and an uncharged model
membrane was analyzed (Figure 1-35).

Figure 1-35 Full-length K-Ras4B with a BODIPY label in G-domain (89)
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Upon incorporation of negatively charged phosphatidylglycerol lipids into the
membrane the protein rotational mobility significantly decreased, suggesting electrostatic
interactions between HVR and bilayer play a great role upon membrane binding.
In summary, the lipid anchors in the hypervariable region may target Ras
isoforms to specific domains of the plasma membrane. Reliable models for investigation
of Ras-membrane interactions are required along with the labels compatible with plasma
membrane and do not influencing protein activity. Incompatibility of chosen membrane
model with the system under study may lead to unpredictable effects.

1.5

FRET Technique for Studying Lipid Domains
Generally, the experiments involving membrane proteins and lipid membrane

domains have limitations due to the size of the objects: they are too small for light
microscopy to be visualized. Fluorescence techniques came to aid for these purposes.
One example, Förster resonance energy transfer (FRET) technique, will be discussed
below.
More than 60 years ago, Theodor Förster described the resonance transfer of
optical excitation energy via dipole-dipole interaction (90). The mechanism of FRET
involves a donor fluorophore in an excited electronic state, which may transfer its
excitation energy to a nearby acceptor chromophore in a non-radiative fashion. A pair of
molecules that interact in such a manner that FRET occurs is referred to as a donoracceptor pair.
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1.5.1

FRET Principle

In the process of FRET, initially a donor fluorophore absorbs the energy due to
the excitation of incident light and transfer the excitation energy to a nearby chromophore,
the acceptor, which subsequently emits the energy:
D + hυ à D*
D* + A à D + A*
A* à A + hυ,
where D=donor, A=acceptor
Figure 1-36 is a Jablonski’s diagram illustrating the coupled transitions involved
between the donor emission and acceptor absorbance in FRET. In presence of suitable
acceptor, the donor fluorophore can transfer its excited state energy directly to the
acceptor without emitting a photon.

Figure 1-36 Jablonski diagram illustrating the FRET process (91)

A few criteria must be satisfied in order for FRET to occur:
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•

The fluorescence emission spectrum of the donor molecule must overlap the
absorption or excitation spectrum of the acceptor chromophore (Figure 1-37). The
degree of overlap is referred to as spectral overlap integral;

•

The two fluorophores (donor and acceptor) must be in the close proximity to each
other (the distance is between 1 to 10 nanometers);

•

The fluorescence lifetime of the donor molecule must be of sufficient duration to
allow the FRET to occur (92).

Figure 1-37 Absorption and emission spectra of an ideal FRET pair. Adapted from
www.olympusmicro.com.

The efficiency of this energy transfer (EFRET) is inversely proportional to the sixth
power of the distance between donor and acceptor (r) making FRET extremely sensitive
to small distances:

EFRET	
  =

!!!

!!! !! !
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where R0 is the Förster radius at which 50% of donor excitation energy is transferred to
the acceptor (93). The Förster radius (R0) depends on the fluorescence quantum yield of
the donor in the absence of acceptor (fd), the refractive index of the solution (η), the
dipole angular orientation of each molecule (K2) and the spectral overlap integral of the
donor-acceptor pair (J) and is given by

R0 =9.78×103×(η-4 ×fd× J)1/6
One way of measuring the energy transfer efficiency is a steady state
measurement of the relative average donor fluorescence intensities in the presence and
absence of the acceptor. However, it requires the concentrations of donor and acceptor
fluorophores to identical, which may be difficult to achieve in practice.

1.5.2

Determination of FRET from Lifetime Data

Another way to estimate FRET efficiency is to measure a fraction of photons
absorbed by the donor that are transferred to the acceptor:

EFRET  =1−

!!"
!!

  

where τDA is the donor lifetime in the presence of the acceptor and τD is the donor lifetime
in the absence of the acceptor. Lifetime measurements allow removing requirement of
equal concentration and makes data more comparable.
Function I (t) describes the intensity as a function of the time t, with I0 as the
intensity at the time t = o and τ as the average lifetime of an electron in the first excited
state before it returns to the basic state by emitting a photon. This is referred to as the
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fluorescence lifetime, the time at which the total intensity drops to 1/e of the initial
intensity:

𝐼 𝑡 =    𝐼! 𝑒

!!

!

If a mono-exponential decay is not sufficient to adequately describe the data, the
equation for multi-exponential decays can be extended:

𝐼 𝑡 =    𝐼! ∗

𝐴! 𝑒

!!

!!

!

In this equation the An represents the relative amplitude of the respective function
to the total component, I0 is the initial intensity of the fluorescence, and τn is the lifetime
of the respective exponential component.

Figure 1-38 Intensity distribution over the arrival times of single photons in an experiment for the lifetime
determination. Blue curve is an instrument response function (IRF), red curve is a sample decay function,
and black curve is a fitted function

64
Experimental detection of the fluorescence lifetime is performed by means of the
so-called time correlated single photon counting (TCSPC) according to the start-stop
method. A pulsed excitation light source is used - a laser or LED with a suitable
wavelength - which supplies the start signal for the measurement. The incident photon
defines the stop signal, the time between start and stop is measured. After repeating the
measurement several times, a histogram is obtained from the distribution of the arrival
times of a photon (Figure 1-38).
The fluorescence lifetime can be determined by means of an exponential
approximation over the available measured data. It should be noted that the laser pulse
has a certain width. This is generally an order of magnitude lower than the fluorescence
lifetime but nevertheless long enough to excite molecules after some of the molecules
have already returned to the ground state. This leads to a shift of the decay curve R (t) to
longer times. The actual fluorescence decay curve F (t) is mixed with the pulse responses
of the laser and detector L (t). This shift can be subsequently corrected from the signal.
For this purpose, the measured signal R (t) is considered and divided into two possible
components: the time profile of the laser including detector L (t) and the actual
fluorescence signal of the dye F (t). The time profile of the pulse response of the laser and
detector is determined with a scattering solution without fluorescent dyes. The two signal
components are linked by a convolution (91).

𝑅 𝑡 =   𝐿 𝑡 ∗ 𝐹(𝑡)
!

𝑅 𝑡 =   

𝐿 𝑡 ∗ 𝐹 𝑡 − 𝑡 ∗ 𝑑𝑡 ∗

!

The unfolding of the two functions follows a non-differentiable mathematical
model. Therefore it has to be solved numerically and the least-squares-fit method is used
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as an approximation method. In this case, a measurement signal Rg (t) is generated or
estimated. This signal is then compared with the measured signal and the deviation
between the two is determined. The comparison takes place via the following rule:
!
!

𝑔! (𝑅 𝑡 −    𝑅! 𝑡 )!

𝜒 =   
!!!
2

χ is the measure of the quality of the estimate and gi is a weighting factor for the quality
of the approximation 1 / Ri (t). The process is repeated until χ2 is between 0.9 and 1.2.
In summary, FRET depends upon the extent of spectral overlap between the
donor-acceptor pair, the quantum yield of the donor, the relative orientation of the donoracceptor and the distance separating the donor and acceptor. As a result, FRET is often
referred to as a “spectroscopic ruler”, and can be used for a variety of studies, for
example, protein-protein interactions, conformational changes of a protein or proteolytic
processes.

1.5.3

FRET for Measurement of Size of Membrane Domains

Due to the hydrophobic nature of membrane proteins application of classical
approaches is far more challenging than for soluble proteins (94). Only a few techniques
can be applied, including FRET (95) and AFM (96). FRET technique is unique among
these examples, as it is non-invasive and very sensitive to small concentrations. This is an
especially relevant consideration for nanodomains, where even small perturbations might
tip the delicate balance of interaction energies and cause significant artifacts in size
measurements. This technique can be applied to any molecular system for which a
fluorescent derivative can be produced.
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Being the native-like component of the plasma membrane of cells, fluorescently
labeled lipids are well suited as membrane probes. Depending on the length and
saturation of the acyl chains such lipid analogues localize in different lipid domains and
called lipid domain markers (97). As mentioned above, lipid domains, which coexist in a
phospholipid membrane, have different biophysical properties. For example, NBD-DPPE
can be used to discriminate liquid ordered domains. In contrast, head group labeled Nrhodamine-DOPE (Rhod-DOPE) shows disordered domain partitioning.
Measuring FRET between two fluorescent membrane probes allows estimation of
the membrane domains size. For these experiments, the bilayer is labeled with two
membrane probes—with a known preferential enrichment in a certain lipid environment,
which forms an adequate FRET-pair (Figure 1-39).

Figure 1-39 Schematic representation of FRET in lipid membrane domains. Left – no lipid domains are
present. Right – donor and acceptor located in the same lipid domain, high FRET is observed

As mentioned above, the cellular lipid domains are small on the order of a few nm.
Recent studies have shown that in model membranes with realistic plasma membrane
lipid compositions, i.e., sphingomyelin/1-palmitoyl,2-oleoyl
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phosphatidylcholine/cholesterol (SM/POPC/Cholesterol), Lo domains can produce small
domains(98). In this case, Lo domains cannot be identified by FRET pairs having a large
(~50 Å) donor-acceptor interaction radius (Ro), but may be detected using FRET pairs
and short-range quenchers with small (12–25 Å) interaction range (99).
One example represented by work of P. Pathak and E. London (98). Group used
FRET between fluorescent lipids to examine the composition- and temperaturedependent phase behavior of SM/POPC/Cholesterol. FRET is sensitive to changes in the
distribution of donor/acceptor distances that accompany phase separation (100). Briefly,
when a single phase is present, probes are distributed in the bilayer such that FRET
efficiency varies only slightly. Relative to this baseline behavior, FRET efficiency
changes dramatically upon appearing of regions of phase coexistence, depending on the
relative partitioning behavior of the dyes. FRET efficiency is increased in composition
regions where both probes prefer the same phase, and reduced where probes prefer
different phases (101). In this particular work the Ld-preferring probe, Rhod-DOPE (Ldprobe) was used along with NBD-DPPE and DPH, which exhibit significant affinity to
ordered domains (102).
Figure 1-40 represents the melting profiles of two lipid mixtures: mixture A
produced Lo domains due to the presence of sphingomyelin; mixture B represents a fluid
homogeneous bilayer (in the absence of sphingomyelin). The emission of the donor was
measured through the temperature range for the samples with (F sample) or without
acceptors (F0 samples). Then the ratio of F/Fo was calculated and plotted versus the
temperature of the sample.
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Figure 1-40 Detection of ordered domains by FRET pair NBD/Rhodamine (A) 1:1:1 SM/POPC/cholesterol
(raft-containing lipid mixture shows change in FRET upon heating); (B) 2:1 POPC/cholesterol
(homogeneous bilayer, no change in FRET) (98)

In POPC/Chol vesicles, which lack SM and form homogeneous bilayers FRET
was very strong at all temperatures (Figure 1-40, B). In a lipid mixture containing SM
lipid domains were detected at low temperature, as shown by the weaker FRET (higher
F/F0) below 30°C (Figure 1-40, A). It is clearly visible that the bilayer becomes
homogeneous at a midpoint temperature (melting point) around 32°C, as all Lo domains
are gone or small enough to be detected.
FRET ratio changes more dramatically for DPH/Rhodamine FRET pair, which
has a shorter Forster distance of 36 Å comparing with NBD/Rhodamine radius of 50 Å
(Figure 1-41).
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Figure 1-41 Detection of ordered domains by FRET pair DPH/Rhodamine (A) 1:1:1 SM/POPC/cholesterol
raft-containing lipid mixture shows change in FRET upon heating), or (B) 2:1 POPC/cholesterol
(homogeneous bilayer, no change in FRET) (98)

The smaller Lo domains were detected in SM/POPC/Chol at lower temperatures.
Using multiple FRET pairs Pathak and London roughly estimated nanodomains size. The
limitation of this experiment arises from the size of the domains. Strong protection of a
donor inside a domain from acceptor outside the domain requires a Lo domain radius
greater than R0. Therefore, FRET cannot detect domains when domain radius is less than
R0.
In summary, membrane raft size measurements are crucial to understanding the
stability and functionality of rafts in cells. The methods, which involve accurately
measured raft size, are proposed to identify the interaction mechanism of membranecoupled proteins.
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2. Results and Discussion
The aim of this work was to determine a mechanism by which Ras proteins in
different functional state prefer distinct lipid domains. The hypothesis behind this aim is
that native partitioning of Ras is determined by concerted interactions of the G-domain,
C-terminal tail and lipid anchors with the membrane domains. To test this hypothesis, we
evaluated partitioning of H- and N-Ras lipoprotein mimics in lipid raft mixtures via
FRET to lipid domain markers and assessed the distribution of Ras lipopeptides on lipid
raft boundary.
The workflow of this project is schematically represented on Figure 2-1. For
creation a model of study – Ras-LUV complex we had to produce and characterize both
the protein and a membrane mimic. The membrane mimic (LUV) was characterized by
FRET using fluorescence intensity and lifetime-based approaches. In addition, control
experiments were performed to analyze interactions of non-lipidated proteins and
lipidated peptides with LUV. To create the full-length lipidated protein we performed
expression of Ras-181 construct, synthesis of lipidated peptides and coupling reactions.
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Protein expression and isolation (Ch.2.1.1)
Interaction of non-lipidated protein with lipid mixture (Ch.2.3.4)

FRET-based raft detection (Ch.2.2.2)
Lifetime raft detection (Ch.2.3.3)

Lipidated peptide synthesis (Ch.2.1.2)
Interaction of peptide with lipid mixture (Ch.2.3.4)

Lipidated protein
creation
(Ch.2.1)

Lipid mixture
characterization
(Ch.2.2)

Ras-LUV
complex
(Ch.2.3)
Figure 2-1 Schematic workflow of the project. Number in parenthesis indicates the corresponding chapter
of the thesis

In this work, we used recombinant protein expression and chemical synthesis to
create lipoprotein mimics and study their mechanism of interaction with the phospholipid
membrane. To evaluate partitioning of H- and N-Ras lipoprotein mimics in lipid raft
mixtures via FRET to lipid domain we divided the protein in multiple blocks (Figure 2-2).
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Figure 2-2 Schematic representations of Ras protein blocks used in the experiments: block I is Ras Gdomain, block II is lipidated peptide

1. G-domain-containing block I, obtained by bacterial expression using recombinant
gene constructs;
2. Labeled lipidated peptides (block II), synthesized by organic chemistry methods.
Using these building blocks, we were able to create three types of constructs:
A. Lipidated peptides lacking G-domain
B. G-domain lacking membrane-targeting region
C. Semisynthetic full-length protein containing both G-domain and lipidated Cterminus.
Partitioning of proteins in lipid nanodomains was detected by FRET between the
protein construct and lipid domain markers. FRET technique requires having a pair of
fluorophores in the sample of interest as well as in lipids serving as markers of lipid
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nanodomains. To be able to analyze partitioning of all three constructs, the fluorescent
labels have to be introduced in either block I or II.

2.1

Making Lipidated Full-Length Ras Proteins

2.1.1

G-Domain-Containing Block I

Taking advantage from the presence of the nucleotide in Ras-binding site, the
block I can be labeled by the fluorescent analog of the nucleotide. The fluorescent
nucleotide was introduced by the nucleotide exchange reaction, which is driven by large
excess of the labeled nucleotide. For the reaction, we used the following truncated
proteins constructs:
•

N-Ras C118S-181

•

H-Ras C118S -181

2.1.1.1 Expression and Purification of N-Ras C118S-181

The truncation of the N-Ras cDNA was achieved by standard PCR methods. Thus,
a stop codon was inserted into position 182 of the N-Ras cDNA and the resulting PCR
product was cloned into an E. coli expression vector (pET43.1b expression vector).
Protein expression in the E. coli strain was then carried out, the cells were disrupted and
the protein was purified by means of ion exchange chromatography and gel filtration. The
expression route is schematically represented on Figure 2-3.

74

LB
culture

Transformation
BL21*

NRas-C118S-181C pET41.1b
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& refolding before ionic exchange
Figure 2-3 Expression and isolation route for N-RasC118S-181 construct

We observed a low expression level for the constructs N-RasC118S-181 and NRasC118S-181 compared to the short versions Ras-166. One of the reasons is that the
protein was split between two fractions. Lysis supernatant and pellet (lanes 6 and
8,Figure 2-4) approximately in 1:1 ratio.
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Figure 2-4 SDS-Page analysis of expression and purification of N-RasC118S-181 protein. Lanes as follows:
1, 4, 7 – protein ladder; 2 – lysis total without induction; 3 – lysis total after induction with IPTG, 5 – lysis
supernatant without induction; 6 – lysis supernatant after induction with IPTG; 8 – urea solubilization
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However, we purified and analyzed both fractions. The protein originated from
the pellet portion had a superior purity comparing to the supernatant portion (Figure 2-5).
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Figure 2-5 SDS analysis of purification of N-RasC118S-181 protein. Comparison of fractions originated
from lysis supernatant and pellet portions. Lanes as follows: 1, 4 – protein ladder; 2 - pellet fraction; 3 –
lysis supernatant fraction; 5 – pellet fraction (overload); 6 – lysis supernatant fraction (overload)

MALDI TOF analysis revealed identical molecular weight of the purified
fractions, but we decided to use only pellet protein in coupling reaction. The total yield of
the protein originated from the pellet portion was about 2 mg/ 1L of culture media. H-Ras
was expressed similar way. The total yield for slightly higher, about 4 mg/ 1L of culture
media (see Materials and methods for details).
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2.1.2

Synthesis of Lipidated Peptides

To study in molecular detail the parameters that determine the selective
localization of Ras in plasma membrane we used both labeled and unlabeled lipopeptides.
Their synthesis is complicated by the pronounced chemical lability of these compounds.
The methods for synthesis and purification were based of solid-phase technique. Using
described strategy (103), we obtained several compounds:
•

Mant-labeled N-Ras peptide;

•

Mant-labeled H-Ras peptide;

•

unlabeled N-Ras peptide;

•

unlabeled H-Ras peptide;

•

MIC-coupled N-Ras peptide;

•

MIC-coupled H-Ras peptide.
Flexible solid phase approach allows generation of labeled and unlabeled

lipidated peptides in one synthetic round. Scheme 2-1 represents the routes for different
lipidated peptides based on N-Ras C-terminal sequence. After introduction of lipid
anchors the peptide is elongated according to the amino acid sequence of desired protein.
At the last stage, the resin bearing lipidated peptide is split into three portions and each
portion is modified by suitable acid derivative. Coupling with mant-acid yields
fluorescently labeled peptides. The addition of maleimidocaproyl acid (MIC-acid) leads
to the formation of compound, which can be coupled with block I to obtain full-length
semi-synthetic protein. Upon capping the amino group with inactive pivalic anhydride the
non-fluorescent peptide is produced, which used for experiments on lipid raft size
alteration.
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Scheme 2-1 Synthesis of N-Ras lipidated peptides

2.1.2.1 Lipidated Peptides for Biophysical Studies with Model Membranes

This part of the work describes the synthesis of lipidated N-Ras proteins for
biophysical studies on model membranes using fluorescence spectroscopy. The human NRas protein consists of 186 amino acids and is doubly lipidated at the C-terminal
hypervariable region: Cys181 is esterified with a palmitic acid and a farnesyl residue is
bound to the terminal Cys186 as a thioether. The terminal carboxyl group is protected as
a methyl ester (Figure 2-6). The H-Ras isoform has additional varieties in hypervariable
region: Cys181 and Cys184 are palmitoylated and Cys186 is farnesylated (Figure 2-7).
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Figure 2-6 Lipidated human N-Ras protein. Drawing not to scale

Figure 2-7 Lipidated human H-Ras protein. Drawing not to scale

The synthetic route for creation of lipidated proteins must meet the following
requirements:
•

The strategy should allow introduction of lipid anchors and fluorescent labels
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•

The linker between the C-terminal tail and truncated Ras protein should not affect
the biological activity of the protein

•

The coupling reaction should proceed with high yields and irreversibly; it should
not lead to protein denaturation.
Based on the work of H. Waldmann and colleagues in which lipidated and

fluorescently labeled Ras proteins were successfully prepared, we used the same strategy
for creation of fully lipidated proteins (56, 104, 105). In this approach a C-terminal
lipidated peptide is synthesized by solid-phase synthesis and coupled to bacterially
overexpressed C-terminally truncated Ras protein. The maleimidocaproyl (MIC)
coupling serves to link the synthetic peptide to the shortened Ras protein (106).
The fluorescent label was introduced to N-terminal part of the lipopeptide (Mantpeptide). It was shown previously that the peptide backbone for membrane bound N-Ras
peptides resides outside of the membrane, while the lipid side chains are embedded into
the phospholipid layer (67). Therefore, such placement of fluorophore ensures that the
label does not interact with the membrane, in contrast to a fluorophore introduced into the
side chain of amino acids.
Due to the number of limitations related to the instability of lipidated cysteine, the
correct choice of the resin linker is crucial. Not so many linkers are suitable in this case.
Therefore it is important to choose suitable protective groups and linker. Due to acidsensitivity of isoprenoid group high concentrations of acid should be avoided, therefore
acid-assisted release of the peptide from the solid support is not possible. In addition, the
desired peptide has to be methylated at the C-terminus, not so many linkers are suitable in
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this case. The Fmoc-4-hydrazinobenzoyl linker was chosen for peptide synthesis since it
allows direct access to the methyl ester after cleavage (107).

Scheme 2-2 Synthesis of lipidated peptides using the hydrazide linker

The first step is the oxidation of the hydrazine to hydrazide, and then, methanol is
used as a nucleophile to release the peptide with a C-terminal methyl ester (Scheme 2-2).
The only drawback of the hydrazide linker is that it requires the use of degassed solvents
and reagents to avoid oxidation before the release of the peptide, which would result in
lower yields. The 9-fluorenylmethoxycarbonyl (Fmoc) group was selected as the amine
protective group since it can be cleaved under mild basic conditions.
The palmitoyl group is highly reactive towards a nucleophilic attack, and once
deprotected, the palmitoyl group can easily undergo an S- to N-acyl shift (Scheme 2-3).
Specific methods are required for coupling as well as for the N-terminal Fmoc
deprotection in order to minimize the formation of side products.

81

Scheme 2-3 S,N-acyl shift scheme

To minimize the possibility off side product formation and avoid difficulties upon
handling the lipidated peptide, the palmitoyl group was replaced by its non-hydrolyzable
analog hexadecyl lipid chain.
Before starting the synthesis of the lipidated peptides on solid phase, it was
necessary to prepare the Fmoc-protected cysteines equipped with the different lipid
modifications. The Fmoc protected N-fluorenylmethoxycarbonyl-S-farnesyl-L-cysteine
(FmocCys(Far)OH) and N-fluorenylmethoxycarbonyl-S-hexadecyl-L-cysteine
(FmocCys(HD)OH) were prepared in solution in good yields after optimization of the
syntheses (See Materials and methods for details).
The synthesis with FmocCys(Far)OH was based on the alkylation of the thiol
group of the cysteine according to Brown (108). In this case, the prenyl chloride in
alkaline NH3/MeOH media was attached to the cysteine. On the second stage, Fmoc-OSu
in the presence of triethlyamine in dichloromethane gave the desired Fmoc-protected
farnesylated cysteine (Scheme 2-4).
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Scheme 2-4 Synthesis of FmocCys(Far)OH

For the synthesis of FmocCys(Pal)OH the SH-protected derivative
FmocCys(Trt)OH was used as a starting point. First, the trityl group was removed with 1%
TFA in the presence of triethylsilane. The reaction with palmitoyl chloride in the
presence of trimethylamine gave palmitoylated cysteine (Scheme 2-5).

Scheme 2-5 Synthesis of FmocCys(Pal)OH

The FmocCys(HD)OH was obtained by applying a thiol-ene reaction to the
deprotected thiol and 1-hexadecene using 2,2’-azobis(2-methylpropionitrile) (AIBN) as a
radical initiator Scheme 2-6 (109).

Scheme 2-6 Synthesis of FmocCys(HD)OH

In order to suppress the racemization 2,4,6-trimethylpyridine was used as the base.
In each case, 4 equivalents of HBTU / HOBT / TMP were used for the attachment of
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cysteine derivatives. The Fmoc groups were cleaved with 20% piperidine in DMF, the
chain extension was carried out with activation with HBTU and HOBt. Lipidated
building blocks were coupled with HBTU/HOBt and steirically hindered
trimethylpyridine (TMP) in DCM/DMF (1:1) to avoid racemization (110). The coupling
times were extended due to the bulkiness of the lipid residues: five hours for coupling of
FmocCys(Far)OH and overnight coupling for FmocCys(HD)OH attachment.
To facilitate the isolation of the final product after each coupling capping
procedure was used after each coupling step. To prevent acylation of the nitrogen atoms
on hydrazide linker during the capping step the sterically hindered pivalic anhydride was
used (106). After the hexapeptide was prepared, the terminal amine was deprotected and
the polymer-bound peptide was extended with maleimidocaproic acid (MIC-OH) or Nmethylanthranilic acid (mant-acid). The cleavage of the product from the resin with
Cu(OAc)2 in dichloromethane yield the peptides (Scheme 2-7). Same strategy was
applied for creation of H-Ras peptides. The presence of Serine and Lysine residues
introduced addition challenge. To ensure the side chain active groups of those residues
won’t be involved into side reactions we used protected derivatives FmocSer(Trt)OH and
FmocLys(Mtt)OH. Both Trt and Mtt protective groups can be cleaved under mild
conditions with 1% TFA in DCM leaving isoprenyl group intact (Scheme 2-8).
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Scheme 2-7 Synthetic scheme for the N-Ras peptides

Scheme 2-8 Synthetic scheme for the H-Ras peptides
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2.1.3

Coupling Reaction

Overexpressed truncated Ras proteins were coupled to C-terminal Ras peptides
via a maleimidocaproyl linker. The protein polypeptide ends with a free cysteine, which
attacks the N-terminal maleimidocaproyl group of the lipopeptide in a nucleophilic
reaction by the cysteine SH group. The exposed position of the cysteine in the highly
flexible C-terminus of Ras makes this reaction almost specific. The maleimide group
reacts specifically with sulfhydryl groups when the pH of the reaction mixture is between
pH 6.5 and 7.5. In addition, cysteine in the protein core was mutated to serine (C118S
mutation) to ensure the correct product without significant side reactions.
Two routes for coupling reaction were explored: a) coupling on LUV surface; b)
introduction of already lipidated protein into LUV (Figure 2-8). First method seemed to
be promising since it ensured attachment of protein to LUV surface (111). However, after
several attempts we were unable to successfully perform the coupling. One of the
possible reasons is that the presence of DOPG lipid adds a negative charge to LUV
surface and obstructs the coupling reaction by repelling negatively charged block I
construct away from the membrane surface.
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Figure 2-8 Coupling reaction routes: (A) LUV containing MIC-lipidated peptides allowed to interact with
RasC118S-181 construct producing protein-LUV complex; (B) coupling reaction between the Ras-181
construct and lipidated peptide followed by addition of obtained lipidated protein to LUV and spontaneous
association with the bilayer

Another coupling route required additional steps, as the generation of lipidated
proteins and it’s purification, followed by introduction of full-length protein into lipid
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mimic. The drawback of this route that the lipidated protein would be incorporated into
LUVs with low efficiency with certain percentage of protein left in aggregated form in
solution. We had to ensure that non-lipidated protein does not react with LUVs.
The coupling of the lipopeptide with the N-Ras protein was performed in a Triton
X-114-containing Tris buffer for 8 hours at 4° following Bader et al. (56). This nonionic
detergent made it possible to keep both the lipophilic peptide and the hydrophilic N-Ras
in solution. The extraction of the obtained lipoproteins could also be easily accomplished
with the aid of Triton X-114 (Figure 2-9) since it is miscible with water below 30 ° C, but
above this temperature it forms its own hydrophobic phase. Hydrophobic proteins, such
as lipoprotein, dissolve in the detergent phase, and uncoupled protein remains in the
aqueous phase so that the lipidated protein could be effectively separated. After the phase
separation at 37 °C, the coupling product was purified from detergents by Amberlite resin
and analyzed by SDS-PAGE and MALDI-TOF (Figure 2-10). Due to the low CMC of
Triton X114, it cannot be removed by simple dialysis. Instead, ion-exchange columns are
normally used for this purpose. We introduced an effective alternative route for removal
of detergent from the reaction mixture using small amounts of Amberlite. Amberlite is
ion-exchange resin, which specifically removes detergent from the solution leaving the
protein behind. This way of detergent removal is superior comparing to others since a
very low amount of the resin has to be added avoiding dilution of the sample.
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Figure 2-9 A. Separation of the non-lipidated protein from the lipidated one. After heating the mixture
separates in two phases: the lipidated protein remains in detergent phase (bottom), non-lipidated protein
enriches in aqueous phase (top); B. Detergent removal by Amberlite beads
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Figure 2-10 Left: SDS-PAGE of the C118S N-Ras protein before (lanes 2 and 4) and after conjugation with
lipidated peptide (lane 3). Right: MALDI-TOF spectra of C118S N-Ras protein before and after
conjugation with the lipidated peptide (the difference of the major peaks is 1315 Da)
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Similarly the so-called chimera H-Ras was obtained and confirmed by MALDI
(Figure 2-11). Chimeras are non-natural Ras proteins comprising the G-domain of one
isoform coupled to the lipidated peptide sequence of another isoform. Chimeras are good
tool to probe specific interaction between G-domain and HVR playing a role in
segregation of protein into specific lipid domains.
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Figure 2-11 MALDI-TOF spectra of C118S H-Ras protein before and after conjugation with the lipidated
N-Ras peptide (the difference of the major peaks is 1315 Da)

2.1.4

Mimicking Two Functional States of Ras

Experiments with samples involving Ras G-domain were performed for both GDP
and GTP states. It is difficult to work with Ras-GTP due to relatively fast GTP hydrolysis.
To mimic Ras-GTP we used its analog – 5'-guanylyl imidodiphosphate GppNHp (Figure
2-12). In this form, one of the oxygen atoms is replaced with amine, producing a slowly
hydrolyzable functional group (112).
Mant- (Abs/Em = 355/448 nm) and Rhod- (Abs/Em = 460/560 nm) fluorophores
exhibit good spectral overlap, which makes them a suitable FRET pair. The mant-guanine
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nucleotides Mant-GDP and Mant-GppNHp (Figure 2-12) are commercially available.
Using Mant- as a donor offers several advantages. First, the fluorescence quantum yield
of Mant fluorophore is relatively high in aqueous solutions, which increases sensitivity of
measurements. Second, the Mant-group is relatively small comparing with over
fluorescent probes, and does not interfere with the Ras function (113).

Figure 2-12 Structures of fluorescent nucleotides Mant-GDP and Mant-GppNHp used for labeling of Ras
proteins

The 2D fluorescence spectra for mant-GDP and Mant-GppNHp loaded N-Ras proteins
represented on Figure 2-13.
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Figure 2-13 2D fluorescence spectra (A) Mant-GDP loaded lipidated N-Ras, (B) Mant-GppNHp loaded
lipidated N-Ras. Tyrosine peak located at ex 280 nm/ em 330nm;mant peak located at ex 360 nm/ em 440
nm
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2.2

Making Biologically Relevant Lipid Bilayer

2.2.1

Lipid Domains

Before introduction of the protein we wanted to explore relative affinity of Ras to
lipid nanodomains we used two types of lipid mixtures for each set of the experiments:
•

homogeneous non-raft mixture (POPC/DOPG);

•

lipid raft-containing mixture: SM/POPC/Cholesterol;
Homogeneous mixture served as a control for experiments with raft-containing

mixtures. It contained 2% of negatively charged DOPG lipids to mimic the inner
membrane leaflet, where Ras proteins reside. The raft mixture was also negatively
charged due to the presence of 2% Rhod-DOPE. Type 2 lipid mixtures exhibit
nanodomains of ~7 nm radius (Figure 2-14) (98).

~1

nm

~4-15 nm

~200 nm

~5 nm

Figure 2-14 A schematic drawing of lipid vesicle and nano-scale raft domains (approximately to scale)
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2.2.2

FRET-Based Detection of Lipid Nanodomains

The ternary lipid mixture SM/POPC/Cholesterol was shown to have phase
separation and often called canonical model raft mixture. The POPC forms a liquid
disordered (Ld) phase, whereas SM/Chol mixtures with a molar ratio close to 1:1 form a
liquid-ordered (Lo) phase (114). As seen on tertiary diagram (Figure 2-15) there is a
broad phase coexistence area at room temperature, however the exact location, shape, and
boundaries of the Ld/Lo coexistence region appear to vary with the method of
observation (115).

Figure 2-15 Simplified phase diagram for a ternary mixture of SM/Cholesterol/POPC at 25°C (115). The
coexistence of Lo and Ld phases shown in gray

To detect the presence of nanodomains we used methodology described by Pathak
and London (98). In our study, we examined eSM/Chol/POPC (egg sphingomyelin was
used instead of bovine) system utilizing fluorescence resonance energy transfer (FRET)
between DPH (donor; partitions evenly between ordered and disordered domains) and
Rhod-DOPE (acceptor; partitions strongly into Ld domains). An effective R0 of this pair
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is 36 Å (102, 116). The simplest way to measure FRET is by calculation of the ratio of
donor fluorescence intensities F/F0, where F sample contains both donor and acceptor,
and F0 sample contains only donor.
The principle of FRET-based detection of lipid nanodomains is illustrated in the
Figure 2-16. The purple shape represent lipid raft. Red spheres represent FRET acceptors
(Rhod-DOPE) and green spheres represent FRET donors (DPH). The significant energy
transfer is expected when an acceptor is within the radius R0 of a donor.

A
A

R0

A

D

A

Figure 2-16 Schematic representation of the lipid probes segregation into phases. D is a donor, A is an
acceptor. R0 is an effective distance at which 50% of the donor fluorescence is transferred to an acceptor

One difficulty of domain detection arises from temperature dependence of the
domain's size. At low temperatures, the liquid –ordered (Lo) domains are relatively large.
As the temperature is increased, these domains become smaller, and at 37˚C segregated
domains typically are no longer detectable by given donor/acceptor pair (with R0’).
However, it is possible to detect inhomogeneities on shorter distance scales by another
FRET pair (with R0’’<R0’) (Figure 2-17). These nanodomains may be more relevant to
biological membranes than the larger domains formed at lower temperatures.
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Figure 2-17 The size of lipid rafts decreases upon melting. The actual size of lipid raft is not detectable
after certain point for the particular FRET pair since R0 is greater than the size of the domain

LUVs were prepared by mixing of bulk lipids (SM/POPC/Chol) and addition of
donor only (F0) or donor and acceptor lipids (F) (see Materials and methods for details,
Chapter 4.16). Two F0 samples and two F samples were heated (or cooled)
simultaneously with a rate 0.5°C /min and the intensity of both dyes were detected. The
FRET measurements were repeated 4 times for each F0 and F samples, and the final F/F0
ratio was calculated by averaging. Excitation of DPH in the presence of Rhod-DOPE
within a distance comparable to R0 (or shorter) resulted in a decrease in DPH emission,
indicating that energy transfer had taken place.
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Figure 2-18 Top: Presence of rafts in SM/POPC/cholesterol lipid bilayers detected by FRET between lipid
domain markers. Heating and cooling profiles of the homogeneous and raft LUV solutions with the DPH
(0.1% mol) and Rhod-DOPE (2% mol) donor/acceptor pair at a scan rate of 0.5 oC/min. Each curve is an
average of two independent samples. Fluorescence intensity ratio, F/F0, is calculated using DPH emission
of F and F0 samples, containing and lacking Rhod-DOPE, respectively. Bottom: schematic representation
of distribution of donors and acceptors in raft-containing samples upon heating

Figure 2-18 shows F/F0 versus temperature of the samples upon heating and
cooling of the samples. Similarity of heating and cooling profiles confirmed reversibility
of phase transitions in the raft bilayer and relative photostability of the fluorophores.
Homogeneous bilayer (red and blue) did not reveal dramatic changes in F/F0 as
anticipated. Reduced FRET at low temperature (high F/F0 value) in raft samples (green
and purple) reflects segregation of donor and acceptors in different lipid phases. As
temperature was increasing to 40°C the domains were melting, leading to increasing
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FRET (reduced segregation). After approximately 45°C the bilayer was homogeneous, no
phase coexistence was detected, which is in agreement with literature data (117).

2.2.3

Microscopy of Supported Lipid Bilayers

To verify that the lipid-raft mixture creates nano-scopic (not microscopic)
domains, we made a supported bilayer using the lipid raft mixture and observed them in a
confocal microscope. The spreading of small lipid vesicles on hydrophilic solid supports,
pioneered by McConnell et al. (118), is a simple route to form supported lipid bilayers
(SLBs) (Figure 2-19).

Figure 2-19 Formation of supported bilayer on glass from LUVs: LUV solution in a buffer is spread on
acid-treated glass surface producing a supported lipid bilayer
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Figure 2-20 Overlay of images of NBD-DPPE fluorescence (green) and Rhod-DOPE fluorescence (red) in
supported lipid bilayers made of raft lipid mix. Bright yellow spots correspond to aggregated LUV that
were not removed during the wash phase

In a supported lipid bilayer mixture instead of DPH we used NBD-DPPE
fluorescent lipid, a lipid raft marker. Figure 2-20 reveals that on a microscopic scale the
lipid bilayer appears homogeneous; no separated domains were visible, suggesting that
the domains size is well below the limit of resolution of the microscope (∼ 200nm).
Therefore, confocal microscopy of LUVs supported the absence of domains in
SM/POPC/Chol lipid mixture, yet Figure 2-18 shows the melting profile, which confirms
the coexistence of two phases. Taken together these results imply that raft domain size is,
indeed, nano-scopic.
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2.3

Protein-Lipid Interactions

2.3.1

Preferential Localization of C-Terminal Lipopeptides

To reveal a contribution of the lipidated C-terminus of Ras to interactions with
lipid rafts, we evaluated the preferential localization of N-Ras C-terminal lipopeptide in
absence of the G domain. N-methylanthranyl group (mant) was attached to the
lipopeptide N-terminus to serve as a donor fluorophore. Spectral properties of mant are
comparable to DPH, therefore, we expected a similar Förster radius and similar
sensitivity to domain localization.
Heating and cooling profiles of F/F0 for mant-lipopeptide (Figure 2-21) revealed a
pattern, which was opposite to the one observed for DPH in Figure 2-18. Instead of an
initial high F/F0 values indicative of low FRET due to segregation of acceptors from
donors, we observed a lower initial F/F0 values implying co-localization of mantlipopeptide with Rhod-DOPE. Heating lead to increasing F/F0, indicating the reduction of
the FRET efficiency at higher temperatures, which may be explained by dilution of
fluorophores due to melting of rafts (119).

100
1.0

homogeneous

F/F0

0.8

0.6

0.4
0

raft

10

20

30

40

Temperature, °C

50

60

70

Figure 2-21 Top: Non-raft localization of N-Ras C-terminal lipopeptide revealed by FRET to the disordered
domain marker. Heating and cooling profiles of the homogeneous and raft LUV with Rhod-DOPE
(acceptor; 2% mol) in the presence of the mant-labeled N-Ras C-terminal lipopeptide (donor; 0.1% mol).
Fluorescence intensity ratio, F/F0, was calculated using mant emission of F and F0 samples, containing and
lacking Rhod-DOPE, respectively. Each curve is an average of two independent samples. The F/F0 curves
for homogeneous LUV show unexpectedly high (yet relatively constant) values reflecting difficulties with
quantitative subtraction of light scattering caused by LUV; Bottom: schematic representation of distribution
of donors and acceptors in raft-containing samples upon heating

To confirm this interpretation, we used another lipid domain marker 1,2-dioleolylsn-glycero-3-phosphoethanolamine-N-5-dimethylamino-1-naphthalenesulfonyl (DansylDOPE) and recorded the temperature dependence of F/F0 for dansyl group fluorescence
(Figure 2-22). Dansyl-DOPE is localized in a disordered lipid phase due its unsaturated
lipid chains. A similar increasing trend in the temperature dependence of F/F0 values was
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observed confirming localization of mant-labeled lipopeptide to the non-raft disordered
lipid phase.
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Figure 2-22 Disordered domain markers demonstrate increasing FRET upon reduction in raft size. F/F0
temperature dependence for Dansyl-DOPE donor (0.1% mol) incorporated into the homogeneous and raftcontaining lipid bilayers containing Rhod-DOPE (2% mol)

Similar experiment was done for mant-labeled H-Ras lipidated peptide (Figure
2-23). H-Ras has an additional palmitoyl lipid anchor, believed to increase Ras affinity to
lipid rafts. In spite of the presence of the third lipid anchor in the structure of H-Ras
membrane targeting region similar co-localization of mant-H-Ras-lipopeptide with RhodDOPE was observed.
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Figure 2-23 Non-raft localization of H-Ras C-terminal lipopeptide revealed by FRET to the disordered
domain marker. Heating and cooling profiles of the homogeneous and raft LUV with Rhod-DOPE
(acceptor; 2% mol) in the presence of the mant-labeled H-Ras C-terminal lipopeptide (donor; 0.1% mol).
Each curve is an average of two independent samples

2.3.2

Effect of Lipopeptides on Lipid Raft Formation

Experiments with mant-lipopeptide revealed that the lipopeptide is localized in
vicinity of the acceptor fluorophore, Rhod-DOPE. However, we could not distinguish
between the two possibilities: (1) lipopeptide uniformly distributed in the disordered lipid
phase, and (2) lipopeptide concentrated at the boundary of the raft domains. Both
localizations were observed in experiments with different lipid mixtures (69) (120). In
both cases, mant fluorophore will be easily accessible for quenching by rhodamine.
Boundary localization of the lipopeptide may be directly tested by evaluation of
stability of lipid rafts in the presence of different concentrations of the lipopeptide. The
key consideration is that if the additive is attracted to the lipid phase boundary, the
boundary is stabilized (line tension is reduced) (121). In other words, the lipopeptide will
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act as a lineactant and will facilitate breaking the existing rafts into smaller ones to
increase the length of the boundary. The reduction in raft size may be detectable in FRET
experiments because DPH will be more effectively quenched by Rhod-DOPE when rafts
become comparable or smaller than the Forster radius for this FRET pair.
Figure 2-24 shows the heating profiles for raft LUV containing increasing
concentration of the lipopeptide (no fluorophore attached; see Supporting Information for
estimates of the lipopeptide density at the raft boundary). The reduction in F/F0 values
upon heating was associated with melting of lipid rafts. Lipid rafts were not affected by
presence of the lipopeptide as judged by similar sigmoidal patterns of the samples with
0%, 0.1%, and 0.5% of lipidated N-Ras peptide. This observation questions boundary
localization of the lipidated peptide.
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Figure 2-24 Test of a boundary localization of N-Ras C-terminal lipopeptide. Heating profiles for raft LUV
with DPH and Rhod-DOPE and increasing concentration of non-fluorescent lipopeptide. The curves were
shifted along Y-axis to facilitate comparison of the transition region
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2.3.3

Domain Localization of the Lipid Probes Detected by Time-Domain
Fluorescence Measurements

Determination of FRET in heating/cooling experiments was based on
fluorescence intensity measurements, which requires exactly matching concentrations of
donor in F and Fo samples. This is difficult to achieve for protein-lipid samples because
protein incorporation in lipid bilayer is always partially completed. However, FRET may
also be estimated from lifetime measurements that are insensitive to variations of donor
concentration. Life time measurements were widely used for characterization of
environment of the fluorophore labels (122) and lipid microdomains (123), (97). H-Ras
localization was probed by FRET to lipid domain markers (124, 125). In that study the
raft membranes were originating from living cells incorporating all other membraneassociated proteins and therefore, it was impossible to determine whether Ras distribution
was governed by its own affinity to lipid rafts or was mediated by another protein. The
motivation of our work was to create synthetic raft membranes closely mimicking lipid
domain organization of cellular membranes but devoid of all other protein components.
Figure 2-25 demonstrates lifetime of DPH in homogeneous and raft-containing
LUV. The homogeneous and raft mixtures lacking acceptor exhibited relatively
invariable life times throughout full temperature range. In the presence of acceptor, the
donor lifetime in a homogeneous sample is reduced but remains independent of the
temperature. The raft samples containing the acceptor reveal significant drop in DPH
lifetime in a narrow temperature range indicative of raft-melting phase transition. Figure
2-26 demonstrates a corresponding change in FRET efficiency calculated from data in
reflecting greater accessibility of DPH to Rhod-DOPE after rafts are melted. This
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observation is in agreement with data in Figure 2-18, and confirms that we can use
lifetime measurements for determination of protein localization in lipid nanodomains.

Figure 2-25 Raft stability in SM/POPC/cholesterol bilayers evaluated through time-domain fluorescence
measurements. Lifetimes of DPH fluorescence at different temperatures in homogeneous and raftcontaining mixtures in the presence and the absence of acceptor Rhod-DOPE
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Figure 2-26 FRET efficiency calculated using Eq. 1 (see Materials and Methods) from lifetimes of DPH in
Figure 2-25

106
2.3.4

Interaction of Ras Proteins with Lipid Membrane Mimic

In previously described experiments involving Ras and lipid membrane mimics
the proteins were added to bilayers directly before the measurement, without separation
of unbounded protein (126), (127). To analyze the pure sample of the membrane-tethered
Ras we excluded several unwanted interactions, which could introduce bias results. First,
we confirmed that the majority of the signal we measure comes from the membraneassociated Ras (i.e. we had to remove all lipidated protein unassociated with LUVs).
Second, we estimated the percentage of the signal, which comes from the free mant
nucleotides. To ensure that we are able to completely separate unbound mant-nucleotides
and non-lipidated Ras from Ras-LUV conjugates we performed gel-filtration for the
following samples:
•

homogeneous and raft LUV sample labeled with 2% Rhod-DOPE to establish
elution range of LUVs

•

non-lipidated N-RasC118S-181 sample labeled with Mant-GDP to ensure their
elution range is significantly distinct from LUVs

•

a mixture of homogeneous LUV sample and non-lipidated N-RasC118S-181
incubated overnight to ensure that G-0domain by itself does not interact with the
bilayer

•

lipidated N-RasC118S-181 sample labeled with Mant-GDP to confirm interaction
of lipidated protein with the bilayer
After elution the fluorescence intensity of mant or/ and rhodamine dye was

measured in each tube and plotted on the graph. Figure 2-27 depicts the elution profile of
homogeneous and raft LUV sample labeled with 2% Rhod-DOPE. As expected the LUV
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were eluted in a void volume of a column (tubes 0-2) according to their large
hydrodynamic radius.

Figure 2-27 Elution profile of homogeneous/raft LUV sample labeled with 2% Rhod-DOPE
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Figure 2-28 Elution profile of non-lipidated N-RasC118S-181 sample labeled with Mant-GDP

Similar elution conditions were used for the non-lipidated N-RasC118S-181
sample labeled with Mant-GDP (Figure 2-28). As seen on Figure 2-28 the non-lipidated
protein was eluted according to it’s molecular weight ∼22 kDa, very distinct from LUV
elution range.
Upon elution of the mixture of Rhodamine-labeled LUVs with non-lipidated Ras
bound to mant-GDP the peaks of the corresponding dyes were approximately at the same
molecular weight range as in Figure 2-27 and Figure 2-28, suggesting that the protein
without lipid anchors cannot significantly interact with the lipid bilayer (Figure 2-29).
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Figure 2-29 Elution profile of a mixture of homogeneous LUV sample and non-lipidated N-RasC118S-181
incubated overnight

The lipidated N-Ras protein eluted in a higher molecular weight region
(approx.500 kDa compared to 22 kDa calculated molecular weight) (Figure 2-30). Larger
hydrodynamic radius is likely caused by the presence of the hydrophobic lipid tails,
which induce the formation of micelle-like aggregates comprising a few protein
molecules.
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Figure 2-30 Elution profile of lipidated N-RasC118S-181 sample labeled with Mant-GDP

The lipidated protein samples incubated with LUVs eluted with the shift of the
intensity maximum for Mant- suggesting insertion of the lipidated proteins into the LUV
(Figure 2-31). However, the degree of Ras incorporation in homogeneous and raft-LUV
was different, as revealed by a peak of free lipidated N-Ras unassociated with LUVs.
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Figure 2-31 Elution profile of a mixture of homogeneous and raft LUV sample and lipidated N-RasC118S181 incubated overnight

The number of lipidated Ras molecules in LUV samples was estimated using
Bradford assay, and the corresponding surface density was calculated and represented in
Table 2-1 (see Appendix B for the details). Elution volumes and approximate sizes of
eluted complexes are summarized in Table 2-2.
Table 2-1. Surface density of protein on different types of LUVs

homogeneous LUV sample

Concentration
measured, μg/ml

N-Ras surface
density,
molec/μm2

9 ±2

40,000
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raft LUV sample

3±2

13,000

Table 2-2 Elution volumes and hydrodynamically equivalent size (a globular protein standard) for gelfiltration of Ras-LUV samples on Superose 6 Increase 10/300 GL column (GE Healthcare)

Sample

Elution volume

Corresponding size of a
globular standard

N-RasC118S-181 (no lipid)

25 ml

<30 kDa

Homogeneous LUV

11 ml

>800 kDa

raft LUV

11 ml

>800 kDa

N-Ras-mGDP, lipidated,
no LUV added

15-16 ml

~500 kDa

LUV with N-Ras-mGDP

11 ml

>800 kDa

LUV with N-Ras-mGppNHp

11 ml

>800 kDa

2.3.5

Preferential Localization of N-Ras

To determine the preferential localization of Ras we used FRET measurement
between mant-nucleotides and lipid markers in raft bilayers. Lifetime measurements are
preferable for protein samples to avoid unfolding of the protein upon heating. The
lifetime constants were determined as described in Materials and methods (Ch.4.10.3).
The lifetimes obtained by least-squared fits to the data are summarized in Appendix B.
FRET efficiency was calculated using Eq. 1:
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E = 1−

τ DA
τD ,

Eq.1

where τ DA and τ D are the life times of donor in the presence and the absence of the
acceptor (F and Fo samples), respectively. Standard deviation of FRET efficiency was
estimated assuming independent errors of life times expressed by the Eq.2:
2

$ δτ ' $ τ δτ '
δ E = & DA ) + & DA 2 D )
% −τ D ( % τ D (

2

Eq. 2

An average FRET efficiency values for GDP- and GppNHp-loaded N-Ras
proteins in homogeneous and raft LUVs at 5 °C are shown in Figure 2-32 (complete
dataset if lifetimes can be found in Appendix B). High FRET efficiencies were observed
for both homogeneous samples (mGDP and mGppNHp-loaded) indicating significant
energy transfer from the donor (mant) fluorophore to the acceptor (rhodamine). This
result was expected, since there is no phase separation in the bilyaer. In lipid raft samples
the mGppNHp-loaded protein showed similarly high FRET efficiency reporting on easy
accessibility of mant to rhodamine, which indicated that proteins is relatively excluded
from rafts. In contrast, N-Ras-mGDP exhibited very low FRET values indicating
effective segregation of mant-labeled Ras-GDP from Rhod-DOPE.
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Figure 2-32 Efficiency of FRET between mant and Rhod-DOPE in samples of N-Ras-mGDP and N-RasmGppNHp at 5 oC. Error bars indicate standard deviations from replicate lifetime measurements (for the
numbers of replicates see Appendix B). The raft LUV sample preparations were repeated to increase
confidence in the result (indicated as prep #1 and #2, accordingly)

Similar measurements were performed for a “chimera” construct consisting of HRas G-domains coupled to N-Ras C-terminal lipidated peptide. As seen on Figure 2-33 all
samples showed relatively high FRET efficiency independent on type of the nucleotide in
both homogeneous and raft bilayers. In addition, the absolute value of FRET efficiency in
homogeneous-mGppNHp, raft-mGppNHp and raft-mGDP samples was significantly
higher comparing to homogeneous-mGDP suggesting that mant was more easily
accessible for quenching by rhodamine.
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Figure 2-33 Efficiency of FRET between mant and Rhod-DOPE in samples of H-Ras-chimera-mGDP and
H-Ras-chimera-mGppNHp

As an internal control, we attempted to convert raft samples into a
"homogeneous" state by heating to 37 °C when much of the raft phase is gone. However,
at this elevated temperature all homogeneous and raft LUV samples displayed near-zero
FRET efficiencies suggesting that mant-nucleotides are completely separated from RhodDOPE. This separation might be due to dissociation of mant nucleotides from N-Ras
upon heating considering long (1-4 hours) acquisition times of the TCSPC experiment
and the weaker affinities of mant-nucleotides to Ras relatively to GDP and GTP.

2.3.6

Nucleotide Exchange of N-Ras Bounded to Lipid Mimic

FRET analysis of N-Ras association with lipid nanodomains presented in Figure
2-32 revealed that N-Ras in the GDP-bound form (signaling-inactive state) concentrates
in rafts and exits into the disordered phase upon binding of a GTP-mimic. We attempted
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to recapitulate this property in one sample and see how FRET will change upon the
nucleotide exchange in protein associated with LUVs. We used mGDP-loaded samples
associated with raft LUVs as a starting point. The FRET efficiency measurement
replicated the results from the Figure 2-32 study with the nearly zero values for mGDPRas in raft-LUVs. Then the samples were subject to the nucleotide exchange followed by
another purification. As expected, the fluorescence intensity of both donor and acceptor
decreased significantly, however the lifetimes were still measurable. Contrasting to high
FRET efficiency values in raft-GppNHp samples in Figure 2-32 the FRET efficiency in
samples after nucleotide exchange was still low (nearly zero) (see Appendix B for actual
values). These results suggested that the exchange procedure utilized in this experiment
was not reliable. In the future work, the nucleotide exchange may be catalyzed by a
specific GEF to achieve on-LUV activation.
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3. Summary and Conclusions
About thirty years ago the existence of membrane microdomains was postulated
using number of biophysical techniques (128, 129). The idea of membrane
inhomogeneity led to reevaluation of a concept of membrane-associated proteins and
their role in cell signaling (18). Two phases coexist in biological membrane: liquid
disordered and liquid ordered. The latter is enriched in cholesterol and sphingolipids and
known as lipid raft (130). Lipid rafts are present in both the inner and the outer leaflets of
an asymmetric cell membrane (131), and form communication membrane platforms
allowing tight interactions of signaling molecules together (132).
There are many membrane proteins incorporated into lipid raft phase. Examples
include transmembrane proteins and GPI-anchored proteins (133, 134). Most of these
proteins are permanently attached to the raft phase in the course of their functional cycle,
but Ras protein is unique example that switches its domain localization according to
protein functional state (135), (83). Thus, K-Ras was preferentially found outside lipid
rafts, and H-Ras localization is regulated by GTP loading (136). In addition, in silico
simulations provided evidence indicating that GTP-bound H-Ras is localized to the
border between the lipid ordered/lipid disordered domains (137). However, the exact
molecular mechanism of Ras partitioning between ordered and disordered domains has
not been detailed in a well-defined model raft membrane.
The goal of our study was to evaluate lipid domain preferences of Ras in a
synthetic lipid raft membrane. Use of in-vitro lipid bilayer mimic allowed identifying
specific interactions that Ras makes with the lipid domains in the absence of other
cellular proteins. One of the difficulties of mimicking natural lipid rafts that their size is
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comparable to the wavelength of visible light making natural raft not resolvable in optical
microscopes (138, 139). To create such nano-scale lipid domains, we utilized
sphingomyelin/POPC/Cholesterol large unilamellar lipid vesicles and detected
nanodomains with FRET. To calculate FRET we established two parallel measurements:
intensity and lifetime-based approaches.
It was crucial to use faithful mimic of a post-translationally lipidated Ras in this
analysis, therefore, we created semi-synthetic Ras protein constructs following a methods
developed by H. Waldman group (140) (110) . The synthesis of full-length proteins was
based on combination of bacterial expression and solid-phase synthesis technique.
Flexible synthetic protocol allowed to make several types of constructs to test our main
hypothesis about native partitioning of Ras, determined by concerted interactions of the
G-domain and lipid anchors with the membrane domains.
We assessed the preferential localization of C-terminal lipopeptides for N-Ras and
H-Ras isoforms and determined that the part of the hypervariable region was relatively
excluded from rafts for both isoforms. We also tested the effect of lipopeptides on
formation of the lipid rafts and found that lipid rafts stability was not affected by the
presence of the N-Ras peptide. This funding indicated membrane-anchoring part of the
protein is not involved in alteration of the bilayer.
Measurements of lifetime of mant-labeled Ras proteins associated with rhodamine
containing LUVs allowed us to determine localization of semisynthetic lipidated Ras. We
used both mant-GDP and mant GppNHp to mimic two functional states: the signalinginactive, GDP-bound N-Ras was found to have preferential affinity for lipid rafts. N-Ras
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in its activated conformation (bound to a GTP-mimic, mant-GppNHp) was localized
outside of the rafts, at the raft boundary or in a disordered lipid phase.

Figure 3-1 Left: H-Ras isoform catalytic domains structure (PDB ID 5p21). Right: lipidated H-Ras isoform
structure. Residue differences in catalytic domains of H-Ras and N-Ras are shown as sticks. Pink –
functionally important protein residues (conserved), green – conservative or semi-conservative mutations,
red – non-conservative mutations

In summary, we demonstrated that N-Ras lipoprotein changes its lipid
nanodomain preferences in a nucleotide-dependent manner in the absence of other
membrane proteins. This indicates that Ras proteins themselves are responsible for the
nucleotide-dependent localization in a living cell. The chimera construct where H-Ras Gdomain was fused to N-Ras lipopeptide did not exhibit affinity to rafts. This finding
indicates that Ras-lipid interaction mechanism depends on the particular sequence of the
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G-domain (Figure 3-1) (H-and N-Ras G domains are homologous, but not identical, see
sequence alignment in Appendix G). It is believed that upon the interaction between the
catalytic domain and the plasma membrane orients positively charged helix 4 residues
R128 and R135 close to the membrane (Figure 3-1), promoting specific electrostatic
attraction to negatively charged lipids (141). Further studies involving mutants in the
lipopeptide and the catalytic G domain parts are needed to identify the structural parts
responsible for such behavior.
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4. Materials and Methods
4.1

Chemicals

Table 4-1 List of the chemicals and suppliers

Name

Abbreviation

Supplier

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycine

FmocGlyOH

Advanced Chem Tech

N-(9-Fluorenylmethoxycarbonyl)-L-proline

FmocProOH

Advanced Chem Tech

N-(9-fluorenylmethoxycarbonyl)-L-leucine

FmocLeuOH

Advanced Chem Tech

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Lmethionine

FmocMetOH

Advanced Chem Tech

Fmoc-N’-methyltrityl-L-lysine

FmocLys(Mtt)OH

Alfa Aesar

Fmoc-O-trityl-L-serine

FmocSer(Trt)OH

Alfa Aesar

N-Fmoc-S-trityl-L-cysteine

FmocCys(Trt)OH

Alfa Aesar

6-Maleimidohexanoic acid

MIC-COOH

Alfa Aesar

N-Methylanthranilic acid

Mant-COOH

TCI America

2-(1H-benzotriazol-1-yl)-1,1,3,3tetramethyluronium hexaﬂuorophosphate

HBTU

Advanced Chem Tech

Hydroxybenzotriazole

HOBt

Advanced Chem Tech
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2,4,6-Trimethylpyridine

TMP

Sigma Aldrich

Trimethylacetic anhydride

Pivalic anhydride

Alfa Aesar

1-Hexadecene

Hexadecene

Alfa Aesar

2,2’-Azobis(2-methylpropionitrile)

AIBN

Alfa Aesar

Palmitoyl chloride

Pal-Cl

Alfa Aesar

Triethylamine

Et3N

Alfa Aesar

N-(9-Fluorenylmethoxycarbonyloxy)succinimide

Fmoc-OSu

Alfa Aesar

trans,trans-Farnesyl bromide

FarBr

Sigma Aldrich

Ammonia solution, 7N in methanol

7N NH3/MeOH

Alfa Aesar

N,N-Diisopropylethylamine

DIPEA

Alfa Aesar

1,1,3,3-tetramethylguanidine

TMG

Sigma Aldrich

Pyridine

Py

Sigma Aldrich

Copper(II) acetate

Cu(OAc)2

Alfa Aesar

Trifluoroacetic acid

TFA

Alfa Aesar

Triethylsilane

TES

Alfa Aesar

Sodium borohydride

NaBH4

Sigma Aldrich

1,2-dipalmitoyl-sn-glycero-3phosphoethanolamine-N-[4-(pmaleimidomethyl)cyclohexane-carboxamide]
(sodium salt)

MCC DPPE

Avanti Polar Lipids
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2-Aminoethanethiol

cysteamine

Alfa Aesar

1,6-diphenyl-1,3,5-hexatriene

DPH

Sigma Aldrich

Cholesterol

Chol

Sigma Aldrich

Triton X-114

TX114

Sigma Aldrich

Chicken egg sphingomyelin

SM

Avanti Polar Lipids

1-palmitoyl-2-oleoyl-phosphatidylcholine

POPC

Avanti Polar Lipids

1,2-dioleoylphosphoethanolamine-N-(Lissamine
Rhodamine B Sulfonyl

Rhod-DOPE

Avanti Polar Lipids

1,2-dioleoyl-sn-glycero-3-phospho-(1'-racglycerol) (sodium salt)

DOPG

Avanti Polar Lipids

1,2-dioleoyl-sn-glycero-3-phosphoethanolamineN-(5-dimethylamino-1-naphthalenesulfonyl)
(ammonium salt)

Dansyl-DOPE

Avanti Polar Lipids

2’-/3’-O-(N'-Methylanthraniloyl)guanosine-5’-Odiphosphate, sodium salt

Mant-GDP

Biolog Lifescience Institute
(Bremen, Germany)

2’/3’-O-(N’-Methylanthraniloyl)guanosine-5’-O[(β,γ)-imido]triphosphate

Mant-GppNHp

Biolog Lifescience Institute
(Bremen, Germany)

Bacto Tryptone

Becton, Dickinson and
Company

Yeast extract

Becton, Dickinson and
Company

Sodium Chloride

NaCl

Sigma Aldrich

Tris(hydroxymethyl)aminomethane

TRIS

Sigma Aldrich
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Ampicillin

Amp

TCI America

Agar

agar

Amresco

Isopropyl β-D-1-thiogalactopyranoside

IPTG

VWR Scientific

Ammonium persulfate

APS

Fisher Scientific

N,N,N',N'-tetramethylethane-1,2-diamine

TEMED

Fisher Scientific

30 % acrylamide solution

30 % AA

Hoefer

Bromophenol Blue

BPB

Fisher Scientific

Sodium Dodecyl Sulfate

SDS

VWR Scientific

β-mercaptoethanol

Dithiothreitol

Sigma Aldrich

DTT

VWR Scientific

All solvents were obtained from commercial suppliers (Thermo Fisher and VWR) and
used without further purification.

4.2

Enzymes

All restriction enzymes and DNA modification enzymes were purchased from MBI
Fermentas (ThermoFisher, USA) and New England Biolabs (Ipswich, MA).
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4.3

Kits

E.Z.N.A Plasmid DNA Mini Kit I, OMEGA bio-tek
QuikChangeII Site-directed Mutagenesis Kit, Agilent Technologies
TOPO-TA Cloning Kit Invitrogen, Life Technologies
QIAGEN Plasmid Midi Kit, Qiagen

4.4

Software

Microsoft Office Excel
Microsoft Office Powerpoint
Microsoft Office Word
Matlab
FelixGX
DecayFit 1.4
MestreNova
ACDLabs
ChemDraw
Adobe Illustrator
EndNote
ApE (A plasmid editor)
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4.5

Equipment

Table 4-2 List of instruments and equipment

Name

Model

Manufacturer

pH meter

Symphony SB90M5

VWR Scientific

Autoclave

L610

Washer Solutions

UV/vis Spectrophotometer

Cary 50 Bio

Varian

PCR machine

Mastercycler personal 5332

Eppendorf

Incubator shaker

I2500 series

New Brunswick Scientific

Centrifuge

5810R 15 amp version

Eppendorf

Centrifuge

Sorvall Lynx 4000

ThermoFisher

Dry heating block

D1100

Labnet International, Inc.

Mini Vortexer

VM-3000

VWR Scientific

Electrophoresis apparatus

Power Ease 500

Invitrogen, Life Technologies

Water bath

VWR

VWR Scientific

Sonifier

Branson 450

VWR Scientific

FPLC System

•

detector

Shimadzu, Japan

SPD-M20A
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•

degasser

DGU-20A

•

communication module

CBM-20A

•

liquid chromatograph

LC-20AT

Rotary evaporator

R-200

Buchi

Solid phase synthesis reactor

50 mL

Chemglass

4.6

Resins and Chromatography Columns

Table 4-3 List of chromatography columns

Name

Manufacturer

Ultrogel Aca54/Superdex S200

GE Healthcare

Monobeads Q column XK 16/40 Q Hypercell resin

GE Healthcare/ Pall

Superose 6 Increase 10/300 GL

GE Healthcare

Jupiter 300 C4 column

Phenomenex

4.7

Bacterial Strains

BL21 CodonPlus ™ (DE3) competent cells
DH5 alpha competent cells
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4.8

Plasmid Vectors

pCR 2.1-TOPO

The vector pCR 2.1-TOPO is a part of Topo TA cloning Kit. This vector bears
Ampicillin- and Kanamycin –resistance genes, which allowed selection. The promoter
used for an expression is a T7 polymerase. The vector map can be found in Appendix A.

pET43.1a(+)

The vector pET43.1a(+) was used as an expression vector for N-RasC118S-181C
and H-RasC118S-181Cs. a part of Topo TA cloning Kit. This vector bears Ampicillinresistance genes. The vector map can be found in Appendix A.

4.9

Oligonucleotides

Table 4-4 List of primers

Name of the primer

5'-Sequence-3'

Description

NRasC118S

GGTGCTAGTGGGAAACAAGTCTGAT

forward primer to
introduce C118S
mutation

TTGCCAACAAGG
NRasC118S-r

CCTTGTTGGCAAATCAGACTTGTTT
CCCACTAGCACC

reverse primer to
introduce C118S
mutation
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NRasC118S181Ter

GATGGGACTCAGGGTTGTTAGGGA
TTGCCATGTGTGGTG

NRasC118S181Ter-r

CACCACACATGGCAATCCCTAACAA
CCCTGAGTCCCATC

forward primer for
truncated 181NRas

reverse primer for
truncated 181NRas

NRasC118S166Ter

GAGAAATACGCCAGTACTGAATGAA forward primer for
truncated 166NRas
AAAACTCAACAGC

NRasC118S166Ter-r

GCTGTTGAGTTTTTTCATTCAGTACT
GGCGTATTTCTC

reverse primer for
truncated 166NRas

4.10 General Experimental Methods
All reactions involving moisture- or air-sensitive reagents were carried out under
argon atmosphere in oven-dried glassware with anhydrous solvents. Purifications by
chromatography were carried out using flash silica gel (32–63 mesh, VWR Scientific).

4.10.1 NMR Spectroscopy

NMR spectra were recorded on either a Varian Mercury+ 300 MHz or a Varian
UnityInova 400 MHz instrument. 1H NMR spectra were calibrated to δ=7.27 ppm for
residual CHCl3. 13C NMR spectra were calibrated from the central peak at δ =77.23 ppm
for CDCl3. Unless otherwise indicated, NMR data were collected at 25 °C. The coupling
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constants J are given in Hertz (Hz). Peak multiplicities are abbreviated as follows: s =
singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of doublets, t =
triplet, m = multiplet, br = broad signal.

4.10.2 Mass Spectrometry

The measurement of the MALDI-TOF mass spectra were recorded on a VoyagerDE ProBioSpectrometryTM workstation PerSeptive Biosystems with dihydroxybenzoic
acid (DHB) as the matrix. The ESI mass spectra were measured with Shimadzu HPLCMS 2020 system. Tandem liquid chromatography/mass spectrometry (LC-MS) was
performed on a Shimadzu LCMS-2020 with autosampler, photodiode array detector, and
single-quadrupole MS with ESI and APCI dual ionization, using a Peak Scientific
nitrogen generator.

4.10.3 Fluorescence spectroscopy

Fluorescence measurements were performed in a QuantaMaster™ 400 Research
Fluorometer (PTI). NBD was excited at 460 nm and the emission wavelength was
scanned from 470 to 700 nm. DPH was excited at 358 nm and the emission wavelength
was scanned from 370 to 700 nm. Mant was excited at 360 nm and the emission
wavelength was scanned from 370 to 700 nm. The slit widths were 5 nm (excitation) and
5 nm (emission). The micro cells (3 mm width), StarnaCells, Inc. were used for
measurements. The temperature ramp was applied as 1°C/min.
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Measurements of steady-state and time-resolved fluorescence were performed
using the Photon Technology International QM40 QuantaMaster system equipped with
Pico-Master 1 time-correlated single-photon counting unit (HORIBA Scientific, Edison,
NJ). A four-position Peltier-based Turret 400 (Quantum Northwest, Shoreline, WA)
allowed for simultaneous temperature control and observation of up to four replicates for
each sample condition. DPH, mant, and dansyl fluorophores were excited at 350, 360,
and 340 nm, and their fluorescence was detected at 425, 440, and 520 nm, respectively.
In heating and cooling experiments, temperature change rate was set 0.5oC. Temperature
differences between the cells were directly tested with a digital thermometer and did not
exceed 0.5oC. Time-domain fluorescence measurements of DPH and mant were done
using the 365 nm LED with a pulse width of approx. 1 ns. The slit widths of the emission
monochromator were adjusted in a range from 1 to 8 nm to maintain the TCSPC
counting rate below 2%. The instrument response function, IRF, was recorded using a
solution of a generic scatterer. Time-domain fluorescence decays were analyzed using
DecayFit software (kindly shared by Søren Preus; available from www.fluortools.com).
The three-exponential decay function was used to model the decay of the fluorophore
fluorescence as well as a contribution of excitation light scattered by LUV in the samples.
The DecayFit software subtracted scattered light using variable contribution of the
IRF while the rest of scattered photons were accounted for by the fast-decaying
component of the three-exponential model (yielding a sub-nanosecond life time). The
second component of the model with the life time on the order of 5-8 ns was used as
representative of the fluorophore life time in the samples. The third life time, typically—
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on the order of 20-40 ns, contributed very small percentage of signal (<5%) and,
therefore, was ignored in the FRET analysis. The life time constants of the second
component of the model obtained by least-squared fits to the data are summarized in
Appendix B.

4.10.3.1 Temperature Ramps Data

All temperature ramps samples were prepared and measured in
duplicates/quadruplicates. QM40/Temp mode was used for data collection. F0 and F
samples data was collected in one run to ensure identical temperature conditions. After
data collection, blank traces were subtracted, F/F0 ratio calculated in Felix GX software
and corrected fluorescent intensity ratio traces were exported into .txt format. Along with
fluorescence intensity ratio traces the temperature ramp traces were exported for each
sample. Using the temperature ramp data the temperature of each sample was
extrapolated and fluorescence intensity ratio data versus temperature was calculated and
plotted.

4.10.3.2 Fluorescence Decays Data

All lifetime samples were prepared and measured in quadruplicates. First, F0
samples lifetimes were measured, followed by F samples. TCSPC-Pol-temp mode was
used for data collection. The following parameters were used for the measurement:
channel count 1024, collection time 1800 sec, delay 160 sec, gain 1. Data for each sample
was collected for 30 min with 3 repeats. After data collection, the group of traces
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representing the same sample (3 repeats) was exported into .txt format (Felix GX). The
data from the repeats was combined using pti_group_average.py script and converted to
DecayFit compatible format using pti_trace_2_DecayFit.py script. The following
parameters were used upon the conversion: start = 5, baseline_end = 20, trace_end = 75,
zero_point = 5. Data was processed in DecayFit software using triple exponent fit model.

4.10.4 Absorbance UV-vis Measurements

All steady-state absorbance measurements were performed in 3 and 10 mm quartz
cuvettes (Starna) using Varian Cary 50 Bio UV-Vis spectrophotometer.

4.10.5 Confocal Microscopy of Supported Lipid Bilayers

The LUVs with the lipid probes were prepared as described below. A small
aliquot of the small-unilamellar vesicles suspension was diluted in PBS buffer, and then
put in contact with freshly cleaned glass dish. The mixture was incubated at 37˚C for 30
min, and rinsed several times with buffer to remove the non-fused vesicles. The confocal
fluorescence microscopy was performed on a Nikon A1R instrument (Nikon, Melville,
USA). Confocal images were taken using the excitation light of an Alexa laser at 480 nm.
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4.11 Molecular Biology Methods
4.11.1 Creation of Expression Vectors for N-Ras C118S-181

The following workflow was used to create an expression vector for NRasC118S-181.

N-Ras-189 (full length) pDW363
TOPO cloning
N-Ras-189 (full length) pCR2.1-TOPO
PCR
N-Ras-189 (full length) pET 43.1b
Mutagenesis
N-Ras C118S (full length)
N-Ras C118S-166C
N-Ras C118S-181C
Figure 4-1 Block scheme for creation of expression vector for N-RasC118S-181C

4.11.1.1 TOPO Cloning

Cloning of amplification products was carried out with the help of TOPO TA
Cloning Kits (Invitrogen, Life Technologies). In this case, the property of the
topoisomerase I was used, which specifically recognizes the pentameric sequence 5´(C/T)CCTT-3´ and forms a covalent bond with the phosphate group attached to the 3´
thymidine. The linearized N-Ras vector was provided with topoisomerase I covalently
bound to each 3´ phosphate for complete reaction.
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4.11.2 Site Directed Mutagenesis

N-Ras sequence was mutagenized by polymerase chain reaction using protocol by
the QuikChange Site-Directed Mutagenesis Kit (Stratagene).
The mutagenesis reaction was prepared following the manufacturer’s protocol containing:
2.5µ10X reaction buffer
25 ng of dsDNA template
1µl (20pM) of forward oligonucleotide primer
1µl (20pM) of reverse oligonucleotide primer
0.5µl of dNTP mix (0.2mM of dATP, dCTP, dGTP, dTTP)
0.5µl of Pfu ultra DNA Polymerase (25 U/µl)
ddH2O to a final volume of 25 µl
The cycle parameters for the QuikChange Site-Direct Mutagenesis method are as
indicated in Table 4-5.
Table 4-5 The PCR cycle parameters used for N-Ras mutagenesis

Segment

Cycles

Temperature

Time

1

1

95°C

30 sec

2

16

95°C

30 sec

3

1

55°C

1 minute

4

1

68°C

1 minute
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The wild type parental pET43.1a(+) (AmpR) plasmid used for genetic
manipulation was previously amplified and isolated from a Dam+ strain of E. coli, thus
yielding a methylated pET43.1a(+) (AmpR) plasmid. The Quick-change PCR kit was
used to create a non-methylated mutated derivative of the pET43.1a(+) plasmid which
was used for subsequent cloning steps. The methylated template plasmid was digested by
adding 1µl of DpnI restriction enzyme to the 50 µl Quick-change PCR reaction (outlined
above) and incubating the sample at 37˚C for 1-2 hrs. Following the DpnI restriction
digestion, the DpnI restriction enzyme was heat-killed by 10 minute incubation at 65˚C.
The sample was then incubated on ice for 1 minute and the non-methylated mutated
pET43.1a(+) (AmpR) plasmid was transformed into bacterial competent cells (DH5alpha)
and plated on to LB +Amp plates for selection of positive transformants. DNA
sequencing was also performed to verify the mutated residue and no additional mutations
within the ORF of interest were present.

4.11.3 Cloning of N-Ras

Truncation of the full-length N-Ras cDNA and the introduction of the point
mutation C118S were achieved using the high-fidelity Pfu DNA polymerase (Stratagene,
La Jolla, CA). For the truncated version of N-Ras a stop codon was introduced to position
181 of the N-Ras C118S cDNA. The resulting fragment N-Ras C118S -181 was purified
and digested with EcoRI and SmaI. It was subcloned into the pET43.1 expression vector
and was transformed into the Escherichia coli strain CK600K (Stratagene).
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4.11.4 Isolation of Plasmid DNA

The isolation of the plasmid DNA was achieved using E.Z.N.A. plasmid DNA
Mini Kit I, Spin protocol. The final concentration of pET N-Ras C118S-181C plasmid
was 0.2 ug/mL.

4.11.5 DNA Sequencing

DNA sequencing was performed at the Functional Biosystems Company,
Madison.
The mRNA sequence alignment of human N-Ras wild type protein (Homo
sapiens neuroblastoma RAS viral (v-ras) oncogene homolog, NCBI reference sequence:
NM_002524.4) and N-RasC118S-181C construct is available in Appendix A. First
mismatch corresponds to C118S mutation and the second one highlights the introduced
stop codon 181.

4.12 Protein Chemistry Methods
This chapter describes the chemicals and biological reagents as well as molecular
biology, cell biology and protein chemistry methods used in this study.

4.12.1 Expression Media Preparation

Luria Broth Medium, pH 7.4: 10 g of Bacto Tryptone, 5 g of yeast extract and 10
g of sodium chloride were mixed and dissolved in 800 mL of ddH2O. After the pH was
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adjusted to 7.4, and the volume of the solution was adjusted to 1L. The solution was
autoclaved.

4.12.2 Antibiotics Stock Solutions Preparation

Ampicillin stock (100 mg/ml): 10g of ampicillin powder were dissolved in 10 mL
of ddH2O. The solution was filtered through 0.2 um sterile syringe filter and stored at 20°C.

4.12.3 IPTG Stock Preparation

2.38 g of IPTG were dissolved in 8 ml of ddH2O. Final volume of the solution
was adjusted to 10 mL. The solution was filtered through 0.2 um sterile syringe filter and
stored at -20°C.

4.12.4 Agar Plates Preparation

1.5% agar in LB media
About 3 g of dry agar was added to autoclaved 200 mL LB media and heated to
50°C until homogeneous solution was obtained. Then the solution was poured into the
sterile plates and kept at 4°C.

4.12.5 Transformation of Plasmid DNA into Competent Cells

The plasmid DNA (10-100 ng) was added to the competent cells and incubated on
ice for 10 min. After incubation for the mixture was placed in water bath (42°C) for 30
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sec and then incubated on ice for 5 min. Next the cells were allowed to recover and grow
in 1mL of LB media without antibiotic for 1,5 hours at 37°C.
For protein expression the plates containing Ampicillin (1%) were used. The cell
culture (100-200 uL) was evenly applied to the surface of the plate with Drigalski spatula
and allowed to grow for 8-12 hours at 37°C.

4.12.6 SDS Page

The SDS-polyacrylamide gel is composed of stacking gel and separating gel.
These gels have different acrylamide concentration and the pH value. Acrylamide forms
polymers through a two-component redox system (APS and TEMED) by the addition of
free radicals in a chain reaction. These are cross-linked into polyacrylamide in the
presence of bisacrylamide. For the samples used in this work 15% bisacrylamide gels
were prepared.

4.12.6.1 4X Separating Gel Buffer Preparation

Tris base (18.17 g) was mixed with 4 mL of 10% (w/v) SDS stock solution, and
then pH was adjusted to 8.8. The final volume of the solution was adjusted to 100 mL.
The buffer was stored at room temperature.
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4.12.6.2 4X Stacking Gel Buffer Preparation

Tris base (3.03 g) was mixed with 2 mL of 10% (w/v) SDS stock solution, and
then pH was adjusted to 6.8. The final volume of the solution was adjusted to 50 mL. The
buffer was stored at room temperature.

4.12.6.3 10% APS Preparation

1 g of ammonium persulfate (APS) was dissolved in 10 mL of ddH2O. The
solution was stored at -20°C.

4.12.6.4 15% SDS-Polyacrylamide Gel Preparation

Table 4-6 Relative quantities of the reagents for preparation of stacking and separations gels

Stacking gel

Separating gel

ddH2O

1.20 mL

1.04 mL

30% acrylamide solution

532 uL

2.26 mL

4X separation gel buffer

-

1.14 mL

4X stacking gel buffer

360 uL

-

10% APS

33.6 uL

67.2 uL

TEMED

3 uL

3 uL
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The gel was poured between two glass plates separated by the spacer. About twothirds of the chamber was filled with the separating gel and 1 mL of isopropanol was
added at the top of the gel to ensure flat edge after polymerization. After polymerization
of the separation gel, the isopropanol was removed, the comb was gently inserted into the
chamber and the stacking gel was poured over the separation gel. After polymerization,
the casting plate was clamped into the gel chamber. The chamber was filled with SDS
electrophoresis buffer, and the protein samples were loaded into the wells. The proteins
were separated at 20 mA per gel and 200 V for about 1.5 h. After completion of the gel
electrophoresis, the gel was removed from the glass plates and stained in the Coomassie
dye for 1-3 hours.

4.12.6.5 4×SDS Sample Buffer Preparation

The following components were mixed: 1.0 g of SDS powder, 2.5 mL of 1M Tris
solution with pH 6.8, 0.5 mL of ddH2O, 4 mL of glycerol, 0.8 mL of 0.1% (w/v)
Bromophenol Blue solution. The mixture was stored at -20°C in 1 mL vials. 0.2 mL of
14.3M β-mercaptoethanol was added to each vial before the use.

4.12.7 Protein Samples Preparation

The protein samples were treated with a suitable amount of 4 × SDS sample
buffer, heated to 100°C for 3 min and after short centrifugation applied to the prepared
polyacrylamide gel.
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4.12.8 Bradford Assay

Protein concentrations were established using both Pierce Coomassie Protein
Assay Kit (Thermo Scientific) and absorbance at 460 nm with the extinction coefficient
of 21600 au M-1 cm-1. Two BSA standard calibration curves were used for the
concentration determination: 25-1500 ug/mL working range and 1-25 ug/mL working
range (see Appendix A for details).

4.12.9 Protein Expression and Isolation

Expression and isolation N-Ras-C118S-181 and H-Ras-C118S-181 as performed
as described earlier (142, 143) with little modifications. In brief, pET-RasC118S-181
DNA was expressed in BL21(DE3) cells under conditions favoring inclusion body
formation (37 °C , 250 rpm) in Luria Broth medium. Protein overexpression was induced
with 1.0 mM IPTG. The expressed protein was allowed to accumulate for 3 h at 37°C.
The cultures were then centrifuged at 3500 g, and the pellet was frozen. Cell pellets were
lysed by osmotic shock in 20 mM Tris, pH 8.0 and sonication. The inclusion body pellet
was further solubilized in buffer containing 6 M urea, 20 mM Tris, pH 8.0, 5 mM MgCl2,
1 mM DTT, and 0.03 mM GDP. The solubilized protein was spun for 10 min at 10,000 g,
and the supernatant was separated from the pellet. The protein was refolded by slow
injection into a refolding buffer (20 mM Tris, pH 8.0, 5 mM MgCl2, 1 mM DTT, 0.3 mM
GDP) to a final dilution ratio of 1:10. The refolded protein was extensively dialyzed
against 20 mM Tris pH 8.0, 5 mM MgCl2, 50mM NaCl, and concentrated using Amicon
filter with 3000 MWCO membrane, loaded onto an anion exchange MonoBeads Q
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column (GE Healthcare) equilibrated with the dialysis buffer and eluted with a linear
NaCl concentration gradient. Eluted fractions were analyzed by SDS-PAGE, and pooled
fractions were concentrated using Amicon centrifugal devices with MWCO of 3000 kDa.
Concentrated protein solution was injected on Superdex S200 (GE Healthcare) column
equilibrated with 20 mM Tris, pH 8.0, 200 mM NaCl, 5 mM MgCl2, 1mM DTT. Purified
protein was eluted as a symmetrical peak corresponding to a molecular weight of
approximately 18 kDa. Final protein yield was 2 mg from 1 L of medium. The final
protein purity was greater than 95% (judged by sodium dodecyl sulfate−polyacrylamide
gel electrophoresis).

4.13 Synthetic Chemistry Methods
Preparation	
  of	
  1a	
  

Sodium iodide (8 mg, 0.052 mmol) and 30% hydrogen peroxide (1.2 mL, 5.2 mmol)
were added to a stirred solution of cysteamine (0.40 g, 5.2 mmol) in water (0.5 mL) at r.t.
The precipitated oil-like cystamine was collected by filtration. The remaining solvent was
removed under vacuum. Rf 0.3 (dichloromethane/ methanol = 1:1). Yield: 0.6 g (mmol,
85 %). 1H NMR (400 MHz, D2O): 3.38 (t, J=8.5 Hz, 2H), 3.24 (t, J=7.0 Hz, 2H), 3.15 (t,
J=8.7 Hz, 2H), 2.8 (t, J=8.7 Hz, 2H). MS (ESI): m/z calculated for 138.03 [M + H]+,
found 138.3 [M + H]+.
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Preparation	
  of	
  1b

	
  
N,N’-dicyclohexylcarbodiimide (0.23 mg, 1.1 mmol) was added to a mixture of Nmethylanthranilic acid (0.15 mg, 0.99 mmol) and 1-Hydroxybenzotriazole hydrate (HOBt)
(0.134 mg, 0.99 mmol) in 15 mL of dry dichloromethane chilled in ice-water bath. The
mixture was stirred for 1 h, and then the ice bath was removed. The formation of white
precipitate was observed. Then cystamine (0.15 mg, 0.99 mmol) dissolved in 5 mL
dichloromethane was added and the mixture was stirred 2 h at r.t. The mixture was placed
in a freezer overnight, and the precipitate was removed by filtration. The desired
compound was purified by silica gel chromatography in hexanes/ethyl acetate = 10:1.
Rf 0.6 (hexanes/ethyl acetate = 9:1). Yield: 0.35 g (0.84 mmol, 85%). 1H NMR (400
MHz, DMSO-d6): 8.5 (t, J=8.5 Hz, 2H), 7.5 (d, J=7.0 Hz, 2H), 7.25 (t, J=8.7 Hz, 2H), 6.6
(d, J=8.7 Hz, 2H), 6.5 (t, J=7.0 Hz, 2H), 3.5 (m, J=8.5, 7.5 Hz, 4H), 3.3 (s, 6H), 2.9 (t,
J=7.5 Hz, 4H). MS (ESI): m/z calculated for 419.15 [M + H]+, found 419.05 [M + H]+.
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Preparation	
  of	
  1c	
  

	
  
The Mant-disulfide (20 mg, 0.05 mmol) was dissolved in dry methanol under argon
atmosphere. The solution was cooled to 0˚C, and sodium borohydride (2 mg, 0.05 mmol)
was added slowly. The ice bath was removed and the mixture was stirred for 1h at r.t.
The reaction was quenched by water, and methanol was removed by evaporation. The
desired compound was extracted with ethyl acetate (3x20mL). The organic phases were
collected and dried over anhydrous magnesium sulfate. Evaporation of the organic
portion provided pure thiol in quantitative yield. Rf 0.45 (hexanes/ethyl acetate = 9:1).
Yield: 0.010g (0.05 mmol, 99%). 1H NMR (400 MHz, DMSO-d6): 8.6 (t, J=8.5 Hz, 1H),
7.6 (d, J=7.0 Hz, 1H), 7.25 (t, J=8.7 Hz, 1H), 6.6 (d, J=8.7 Hz, 1H), 6.5 (t, J=7.0 Hz, 1H),
3.5 (q, J=8.5, 7.5, 2H), 3.3 (s, 3H), 2.8 (t, J=7.5 Hz, 2H). MS (ESI): m/z calculated for
210.1 [M + H]+, found 210.05 [M + H]+.
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Preparation	
  of	
  1d	
  

	
  
Freshly reduced sulfhydryl (50 mg, 0.24 mmol) was dissolved in dry dichloromethane
under argon atmosphere and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[4(p-maleimidomethyl)cyclohexane-carboxamide] (sodium salt) (MCC-DPPE) lipid
(chloroform solution, 10mg/ml, 150uL=1.5 mg, 0.0016 mmol) was added. The mixture
was stirred over weekend under argon. The desired compound was obtained after
purification on glass TLC plate. Rf 0.8 (hexanes/ethyl acetate = 9:1). Yield: 1.5 mg (0.89
mmol, 88 %). MS (ESI): m/z calculated for 1121.7 [M + H]+, found 1121.7 [M + H]+.
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4.13.1 Preparation of the Lipidated Amino Acids
Preparation	
  of	
  2a

7 N ammonia in methanol solution (8 mL) was added dropwise to a solution of Lcysteine hydrochloride monohydrate (0.4 g, 3.3 mmol) in methanol (3 mL) which was
cooled to 0°C under argon atmosphere. After 5 min, trans, trans-farnesyl chloride (0.8
mL, 3.3 mmol) was added and the mixture was stirred for 3 h at 0°C and 1 h at room
temperature. Subsequently, the solvent was removed under reduced pressure and the
residue washed several times with n-pentane to remove residual farnesyl chloride. The
residual solid was suspended in dichloromethane (10 mL) and again cooled to 0°C.
Triethylamine (0.6 mL, 3.6 mmol) and N-(9-fluorenylmethoxycarbonyloxy)succinimide
(1.2g, 3.6mmol) were added and the reaction mixture was stirred at room temperature
overnight. After removal of the solvent under reduced pressure the desired compound
was obtained as a colorless oil. The crude product was purified by flash column
chromatography using gradient of methanol in dichloromethane 0-3%. Rf 0.3
(dicholoromethane/methanol =9:1). Yield: 0.95 g (1.73 mmol, 53% after two steps);
1

H NMR (400 MHz, CDCl3): 7.76 (d, J=7.4 Hz,2H), 7.61 (d, J=7.5 Hz,2H), 7.40 (t, J=7.4

Hz,2H), 7.31 (t, J=7.4 Hz,2H), 5.60 (d, J=8.0 Hz,1H), 5.22 (t, J=7.4 Hz,1H), 5.12–5.06
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(m,2H), 4.63 (m,1H), 4.47–4.39 (m,2H), 4.24 (t, J=7.0 Hz,1H), 3.27–3.15 (m,2H), 3.04–
2.90 (m,2H), 2.14–1.93 (m,8H), 1.68 (s,3H), 1.65 (s,3H), 1.59 ppm (s,6H). 13C NMR
(100 MHz,CDCl3): 75.7, 156.1, 143.8, 141.4, 140.5, 135.6, 131.5, 127.9, 127.3, 125.3,
124.5, 123.9, 120.2, 119.6, 67.7, 53.9, 47.5, 40.1, 40.0, 33.5, 30.5, 27.2, 26.9, 26.2, 18.2,
16.6, 16.5 ppm. MS (MALDI-TOF): m/z calculated for C33H47NO4S: 548.2835 [M +
H]+, found 548.04 [M + H]+.

Preparation	
  of	
  2b	
  

	
  
	
  
To a solution of N-(9-Fluorenylmethoxycarbonyl)-S-trityl-L-cysteine Fmoc-Cys(Trt) OH (3 g, 12.5 mmol) in dichloromethane (75 mL) of trifluoroacetic acid (3.75 mL) and
triethylsilane (2.25 mL) was added. The reaction solution was stirred for 1.5h at room
temperature. The mixture was then co-evaporated with toluene and the residue was
washed with n-pentane to remove the resulting triphenylmethane. The colorless solid was
dissolved in dichloromethane (32.5 mL) obtained was chlorotrimethylsilane (0.72 mL,
5.63mmol) was added and the reaction mixture was heated under reflux for 2h. To the
cooled solution of palmitoyl chloride (4.65 mL, 15.32 mmol) was added and a solution of
triethylamine (1.17 mL, 8.39 mmol) in dichloromethane (22.5 mL) was added dropwise
over 3 h under an argon atmosphere. The reaction solution was stirred for another hour at
room temperature before the solvent was removed under reduced pressure. The crude
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product was purified by flash column chromatography using gradient of methanol in
dichloromethane 0-4%. The compound was isolated as colorless oil. Rf 0.4
(dicholoromethane/methanol =9:1). Yield: 1.32 g (2.26 mmol, 44% after two steps);
1

H NMR (400 MHz, CDCl3): 7.76 (d, J=7.5 Hz, 2H), 7.62–7.55 (m, 2H), 7.40 (t, J=7.5

Hz, 2H), 7.29 (t, J=7.5 Hz, 2H), 5.64 (d, J=7.8 Hz, 1H), 4.62 (m, 1H), 4.39 (d, J=7.2 Hz,
2H), 4.24 (t, J=7.2 Hz, 1H), 3.50–3.34 (m, 2H), 2.59 (d, J=7.6 Hz, 2H), 1.70–1.60 (m,
2H), 1.23 (s, 24H), 0.89 ppm (t, J=6.9 Hz, 3H). 13C NMR (100 MHz, CDCl3): 199.5,
174.5, 156.2, 143.8, 141.4, 127.9, 127.3, 125.4, 120.2, 67.8, 62.8, 54.3, 47.4, 44.5, 32.4,
30.8, 30.12, 30.11, 30.10, 30.08, 30.03, 29.9, 29.8, 29.7, 29.4, 26.0, 23.1, 14.6 ppm. MS
(MALDI-TOF): m/z calculated for C34H48NO5S: 582.3253 [M + H]+, found 581.93 [M
+ H]+.

Preparation	
  of	
  2c	
  

Method	
  1	
  

	
  
	
  
Fmoc-cysteine(Trt)-OH (4 g, 6.8 mmol) was deprotected using similar conditions as in
synthesis FmocCys(Pal)OH. The residue was dissolved in 30 mL of 1,2-dichloroethane
(solvent was degassed under an argon stream in a sonicator bath for 15 min prior to use).
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3 eq of 1-hexadecene and 0.5 eq of 2,2’-Azobis(2-methylpropionitrile) (AIBN) were
added to this solution of the deprotected cysteine, and the mixture was brought to reflux
at 90°C for 3 hours. The solution was cooled to room temperature, and the solvent was
removed under reduced pressure. The resulting residue was purified by flash column
chromatography using gradient of ethyl acetate in hexane 0-15% to provide the desired
product. Rf 0.45 (dicholoromethane/methanol =9:1). Yield: 2.0 g (3.39 mmol, 52% after
two steps). 1H NMR (400 MHz, CDCl3): 7.77 (d, J=7.4 Hz, 2H), 7.61(m, 2H), 7.41 (t,
J=7.4 Hz, 2H), 7.32 (t, J=7.4 Hz, 2H), 4.65 (m, 1H, Fmoc), 4.42 (m, 2H), 4.25 (t, J=7.0
Hz, 1H), 3.05 (m, 2H), 2.56 (m, 2H), 1.57 (t, J=7.2 Hz, 2H), 1.26 (m, 28H), 0.89ppm (t,
J=7.0Hz, 3H). 13C NMR (100 MHz,CDCl3): 174.9, 156.6, 143.7, 141.3, 127.7, 127.1,
125.1, 120.0, 67.4, 53.6, 47.1, 34.2, 32.9, 31.9, 29.7, 29.4, 29.2, 28.8, 22.7, 14.1 ppm;
MS (MALDI-TOF): m/z calculated for C34H49NO4S: 590.3280 [M+Na]+, found
590.3300 [M+Na]+.

Preparation	
  of	
  2c	
  
Method	
  2	
  

	
  
A solution of 1,1,3,3-tetramethylguanidine (TMG) (0.65 ml, 5.2 mmol) in 3 ml of
methanol was added dropwise to a stirred (under argon) mixture of L-cysteine
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hydrochloride monohydrate (0.3 g, 2.5 mmol) in 2 ml of methanol. 0.83 mL (2.7 mmol)
of hexadecyl bromide in dichloromethane was added dropwise to the homogeneous
solution and the reaction mixture was stirred 1 h at 50 °C and then at room temperature
overnight. Subsequently, the solvent was removed under reduced pressure and the residue
washed several times with hexanes to remove residual hexadecyl bromide. Centrifugation
was used to separate fine precipitate from the solvent. The residual solid was suspended
in dichloromethane (6 mL) and cooled to 0°C. Triethylamine (0.25 mL, 1.8 mmol) and
N-(9-fluorenylmethoxycarbonyloxy)succinimide (Fmoc-OSu) (0.60 g, 1.8 mmol) were
added and the reaction mixture was stirred at room temperature overnight. After removal
of the solvent under reduced pressure the desired compound was obtained. The crude
product was purified by flash column chromatography using gradient of methanol in
dichloromethane 0-5%. Rf 0.45 (dicholoromethane/methanol =9:1). Yield: 0.95g (1.6
mmol, 68 % after two steps). 1H NMR (400 MHz, CDCl3): 7.77 (d, J=7.4 Hz, 2H),
7.61(m, 2H), 7.41 (t, J=7.4 Hz, 2H), 7.32 (t, J=7.4 Hz, 2H), 4.65 (m, 1H, Fmoc), 4.42 (m,
2H), 4.25 (t, J=7.0 Hz, 1H), 3.05 (m, 2H), 2.56 (m, 2H), 1.57 (t, J=7.2 Hz, 2H), 1.26 (m,
28H), 0.89ppm (t, J=7.0Hz, 3H). 13C NMR (100 MHz, CDCl3): 174.9, 156.6, 143.7,
141.3, 127.7, 127.1, 125.1, 120.0, 67.4, 53.6, 47.1, 34.2, 32.9, 31.9, 29.7, 29.4, 29.2, 28.8,
22.7, 14.1 ppm. MS (MALDI-TOF): m/z calculated for C34H49NO4S: 590.3280
[M+Na]+, found 590.3300 [M+Na]+.
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4.13.2 Solid-Phase Synthesis Procedures

4.13.2.1 Determination of Resin Loading by UV-vis Spectroscopy

A weighed amount of resin (2 to 5 mg) was washed with 10 mL of 20 %
piperidine in dimethylformamide (v/v) and shaken for 10 min. The absorbance was
measured against reference at λ = 301 nm. The loading was determined according to
Beer’s Law, A = εcd, where ε= 7800 at 301 nm. The concentration, and thus the degree
of occupancy with Fmoc groups, was calculated using the Lambert-Beer's Law (Ɛ = 7800
M-1cm-1).

4.13.2.2 Kaiser Test

The Kaiser test was used to check to completeness of the coupling reactions. This
test is a very sensitive test for primary amines. Ninhydrin reacts with the deprotected Nterminal amine group of the peptide-resin to produce an intense blue color, which allows
qualitative determination of complete coupling reaction.
Kaiser Test Solutions:
Reagent A: 1. 16.5 mg of KCN was dissolved in 25 mL of distilled water and 1.0
mL of solution was diluted with 49 mL of pyridine
Reagent B: 1. 1.0 g of ninhydrin was dissolved in 20 mL of n-butanol
Reagent C: 1. 40 g of phenol was dissolved in 20 mL of n-butanol
10-15 beads of resin were placed in a test tube. 2 to 3 drops of Reagent A, 2 to 3 drops of
Reagent B and 2 to 3 drops of Reagent C were added. The tubes was heated at 110°C for
5 minutes. Colorless or faint blue color indicated complete coupling. Dark blue colored
solution indicated failed coupling and the coupling procedure was repeated.
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4.13.2.3 Cleavage of Fluorenylmethyloxycarbonyl on the Solid Phase

For the removal of the fluorenylmethyloxycarbonyl (Fmoc) protecting group the
following procedure was used in all cases.
Procedure E
A mixture of 20% piperidine in dimethylformamide (v/v) was degassed with
argon for 15 min and added to the polymer. The resin was shaken for 10 min, and then
the process is repeated. Subsequently, the resin was washed five times with dry, degassed
dimethylformamide.

4.13.2.4 Solid-Phase Coupling Procedures

As a first step, the resin was swollen for 30 min with dicholoromethane /
dimethylformamide (1:1) mixture. Subsequently, the Fmoc group was cleaved according
to general procedure E.
Procedure AS1. Coupling of FmocCys(Far)OH
4 eq of FmocCys(Far)OH), 4 eq of 1-Hydroxybenzotriazole hydrate (HOBT) and
4 eq of N,N,N’,’-Tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate, O(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU) were
dissolved in degassed mixture of dicholoromethane/dimethylformamide (1: 1) upon
stirring. Then 4 eq of collidine were added and the solution was incubated for 3min. After
that, the entire solution was added to the resin. After 5h, the resin was washed three times
with dicholoromethane, then three times with dimethylformamide. The loading of the
resin was determined by loading test (described above).
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Subsequently, the Fmoc group was removed according to general procedure E.
Procedure AS2. General coupling procedure
The following coupling procedure was used for coupling of all non-lipidated
amino acids.
4eq of amino acid, 4eq of HBTU and 4eq of HOBt in were dissolved in
dimethylformamide. Then 8eq of N,N-Diisopropylethylamine (DIPEA) were added and
the mixture was incubated for 2min before it was added to the resin. After 2 hours, the
resin was filtered off and then washed several times with dimethylformamide. The
completeness of the coupling was checked with the Kaiser test (described above). In the
case of incomplete coupling, the coupling procedure was repeated. Double coupling was
performed after introduction of the lipidated amino acids.
Subsequently, the Fmoc protecting group was removed according to general
procedure E.
Procedure AS3. Coupling of FmocCys(HD)OH
FmocCys(HD)OH (4 eq), 4 eq of HOBt and 4 eq of HBTU were dissolved in
dicholoromethane/dimethylformamide (1:1) mixture, followed by addition of 4 eq of
collidine and 3 minute incubation. After that, the entire solution was added to the resin.
After overnight (8h) shaking under argon atmosphere, the resin was washed three times
with dicholoromethane, then three times with dimethylformamide.
At the next step the Fmoc protecting group was removed according to general
procedure E.
After that, the resin was washed with dimethylformamide (5 times),
dicholoromethane (5 times) and dimethylformamide (5 times).
Procedure AS4. Coupling of 6-maleimidohexanoic acid MIC-COOH
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For the N-terminal attachment of the maleimidocaproic acid the Fmoc protecting
group was removed by general procedure E. Then, a solution of 5eq 6Maleimidohexanoic acid (MIC-COOH), 5eq HBTU, 5 eq HOBt and 5eq DIPEA in
dimethylformamide was allowed to couple for 3h. After completion of coupling, the resin
was washed five times with dimethylformamide.
Procedure AS5. Coupling of N-methylanthranilic acid Mant-COOH
For the N-terminal attachment of the N-methylanthranilic acid the Fmoc
protecting group was removed by general procedure E. Then, a solution of 5eq Nmethylanthranilic acid (Mant-COOH), 5eq HBTU, 5 eq HOBt and 5eq DIPEA in
dimethylformamide was allowed to couple for 3h. After completion of coupling, the resin
was washed five times with dimethylformamide.

4.13.2.5 Capping

For the capping of unreacted amino groups the mixture of pivalic anhydride/
pyridine (1:1) was used. The mixture was added to the resin and shaken for 5 min. After
that the resin was washed 5 times with dimethylformamide.

4.13.2.6 Elimination of the Lipopeptide

Before the cleavage of the peptide, the resin was washed three times with dry
dicholoromethane.
A solution of copper (II) acetate Cu(OAc)2 (0.55eq), pyridine (35eq), acetic acid
(35eq), and methanol (215eq) in dicholoromethane was added. The cleavage reaction was
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conducted in an open reactor, as the presence of oxygen was required. The resin was
shaken for 2.5 h and washed by filtration several times with dicholoromethane. The crude
product was co-evaporated several times with toluene and then purified.

4.13.2.7 Elimination of Mtt and Trt Protective Groups

The resin was washed three times with dry dicholoromethane. Then the resin was
treated with a 1 % trifluoroacetic acid (TFA) and 2 % triethylsilane (TES) solution in dry
dicholoromethane (v/v/v) and shaken for 1 h under argon atmosphere. The crude product
was co-evaporated several times with toluene and then purified.

4.13.2.8 Purification of the Lipopeptides

The copper salts were removed from the crude reaction mixture by the following
procedure. The dry crude mixture was dissolved in dicholoromethane and washed with a
0.1 M solution of HCl in water. The organic phase was dried under magnesium sulfate,
filtered, and the solvent was eliminated under reduced pressure.
For the purification of the lipopeptides two routes were used. a) The lipidated
peptides were purified on silica gel column using a 0–5 % gradient of methanol in DCM;
or b) by preparative HPLC using a C4 column (Phenomenex). The detection was at 210
or 260 nm; flow rate 25 mL/min; total time 30 min; solvents: A—0.1 % TFA in water,
B—0.1 % TFA in acetonitrile; gradient: 10 % B for 1 min, from 10 % B to 100 % B over
23 min, 100 % B for 2 min, 10 % B for 4 min. In both cases the identity of products was
be confirmed by LC–MS.
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Preparation of the lipopeptide MIC-Gly-Cys(HD)-Met-Gly-Leu-Pro-Cys(Far)-OMe

	
  
For this purpose, 300mg resin was used and swollen. The Fmoc was removed by
procedure E and FmocCys(Far)OH was coupled by procedure AS1. Then the coupling of
amino acids was performed according to the general procedures AS2-AS3. The 6maleimidohexanoic acid was coupled using procedure AS4. Finally, the peptide was
cleaved off by 17.8mg copper (II) acetate, 510 uL pyridine, 430 uL acetic acid and
1.54mL of methanol in 8 mL DCM. The peptide was purified by preparative HPLC or
column chromatography. Rf 0.4 (dicholoromethane/methanol =9:1). Yield: 0.012g (20%).
MS (ESI): m/z calculated for C68H114N8O11S3 1315.8 [M + H]+, found 1315.75 [M +
H]+
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Preparation of the lipopeptide Mant-Gly-Cys(HD)-Met-Gly-Leu-Pro-Cys(Far)-OMe

The synthetic procedure is similar to the one above, except that N-methylanthranilic acid
was used instead of 6-maleimidohexanoic acid. The N-methylanthranilic acid was
coupled using procedure AS5. Rf 0.4 (dicholoromethane/methanol =9:1). Yield: 0.017g
(34%). MS (ESI): m/z calculated for C66H111N8O9S3[M + H]+ 1255.8, found 1253.7
[M + H]+.

Preparation of the lipopeptide (CH3)3CC(O)NH-Gly-Cys(HD)-Met-Gly-Leu-ProCys(Far)-OMe
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The synthetic procedure is similar to the one above, except that after introduction of
FmocGlyOH and Fmoc deprotection, the reaction mixture was capped using the capping
procedure (described above). The peptide was cleaved from the resin through elimination
procedure. Rf 0.4 (dicholoromethane/methanol =9:1). Yield: 0.022 g (20 %). MS (ESI):
m/z calculated for C63H111N7O9S3[M + H]+ 1204.8, found 1204.5 [M + H]+

Preparation of MIC-Gly-Cys(HD)-Met-Ser-Cys(HD)-Lys-Cys(Far)-OMe

For this purpose, 300mg resin was used and swollen. The Fmoc was removed by
procedure E and FmocCys(Far)OH was coupled by procedure AS1. Then the coupling of
FmocLys(Mtt)OH was performed according to the general procedure AS2. The
FmocCys(HD)OH was coupled using procedure AS3. Next couplings of lipidated and
non-lipidtaed amino acids were performed according to AS2 and AS3 procedures,
correspondingly. Finally, the peptide was cleaved off by 18.8mg copper (II) acetate, 600
uL pyridine, 480 uL acetic acid and 1.86mL of methanol in 10 mL DCM. The peptide
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was purified by column chromatography. The Trt and Mtt protective groups were
removed according to the described procedure. The deprotected peptide was purified by
column chromatography. Rf 0.4 (dicholoromethane/methanol =9:1). Yield: 0.006 g (8%).
MS (ESI): m/z calculated for C68H114N8O11S3 [M + H]+ 1508.8, found [M + H]+
1508.8.

Preparation of Mant-Gly-Cys(HD)-Met-Ser-Cys(HD)-Lys-Cys(Far)-OMe

The synthetic procedure is similar to the one above, except that N-methylanthranilic acid
was used instead of 6-maleimidohexanoic acid. The N-methylanthranilic acid was
coupled using procedure AS5. Rf 0.4 (dicholoromethane/methanol =9:1). Yield: 0.007 g
(10%). MS (ESI): m/z calculated for C68H114N8O11S3 [M + H]+ 1643.6, found [M +
H]+ 1643.8.
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4.14 Precondensation of TX-114
The precondensation procedure was performed to remove hydrophilic impurities
from the commercial TX-114 (Sigma Aldrich). For this purpose 30 mM Tris pH 7.4, 100
mM NaCl buffer was used. 1.2 g of TX-114 was mixed in clear plastic tube with 40 mL
of cold buffer. The mixture was incubated on ice for 10 min and mixed occasionally.
Then the mixture was transferred into warm water bath (37-40°C) until it became cloudy
and centrifuged for 7 min, 5,000 rpm at 37°C. The centrifuge was heated ahead of the
time and the brakes were set to zero. After the centrifugation the upper phase was
discarded, a new portion of ice-cold buffer was added and the separation procedure was
repeated. Such washing procedure was repeated at least 3 times. The final purified TX114 solution was stored at -20°C (1 mL aliquots).

4.15 Conjugation Reaction and Purification of Lipidated Protein
Before the conjugation reaction purified N-Ras-C118S-181 protein at
concentration about 10 mg/ml was dialyzed against “coupling” buffer (20 mM Tris, pH
7.4, 5 mM MgCl2) to remove DTT and excess NaCl, which may interfere with coupling.
Lipidated peptide (1.5 eq) was solubilized in small amount of methanol and Triton X-114
was added. Peptide solution was sonicated and added to the protein. The reaction mixture
was flushed with argon and incubated overnight at 4°C on rotator. Next day the mixture
was spun for 12 min at 14,000 rpm and the supernatant was transferred to clean plastic
tube. The reaction was quenched by addition of cold 20 mM Tris, pH 7.4, 5 mM MgCl2,
1 mM DTT (2x dilution). The mixture was heated to 37°C until solution became cloudy
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and centrifuged for 10 min at 3,500 rpm. Detergent and aqueous phases were separated
and washed with a fresh DTT-containing “coupling” buffer or Triton X-114, respectively.
All detergent phases were combined and diluted with cold DTT-containing “coupling”
buffer (10x dilution). Then Amberlite XAD-2 (Supelco) beads prewashed with “coupling”
buffer were added to the detergent mixture (to exceed concentration of Triton X-114
approximately 20 times) and incubated overnight at 4°C on rotator. The mixture was
filtered and assessed by Bradford assay, UV-vis, SDS-PAGE and MALDI-TOF.

4.16 Preparation of Large Unilamellar Vesicles
Lipids and fluorescent analogs were dissolved in chloroform (with the exception
of DPH, which was dissolved in ethanol) and stored at -20°C. The concentrations of
fluorescent lipids were determined by absorbance using ε(Rhod-DOPE) 88,000 M-1cm-1
at 560 nm, ε(DPH) 84,800 M-1cm-1 at 352 nm, and ε(Mant-GDP) 22,600 M-1cm-1. Large
unilamellar vesicles were prepared similar to as described previously (98). Lipids,
fluorophores and peptides were mixed in glass vials. The chloroform was evaporated
under a stream of nitrogen gas, and the dried lipid film was rehydrated in 20 mM Tris, pH
7.4, 5 mM MgCl2, 150mM NaCl buffer at 70°C. To form 200 nm–sized unilamellar
liposomes, the mixture was passed 21 times through a polycarbonate filter with a pore
size of 200 nm (Avanti Polar Lipids). Total lipid concentration was 0.5 mM for melting
experiments. Samples for Ras-LUV conjugation contained 1 mM total lipids. Background
was acquired using samples lacking fluorescent probes.
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4.17 Preparation of Ras-LUV Conjugates
At first step lipidated Ras samples were subject to the nucleotide exchange. For
introduction of GDP-analog, the GDP nucleotide associated with the GTPase site in Ras
was replaced with the (2’-(or-3’)-O-(N-Methylanthraniloyl) guanosine 5’-diphosphate
(mant- GDP) using the EDTA-assisted method (144). In brief, the magnesium ions in the
protein samples were chelated with EDTA added to 6 mM along with the 0.8 mM mantGDP and additional 10 mM DTT. The reaction mixtures were incubated for 2 h at room
temperature, and mixed with LUV solution. Ras-LUV mixtures were incubated overnight
at 4 °C and injected onto Superose 6 column equilibrated with 30 mM Tris, pH 7.4, 5
mM MgCl2, 150 mM NaCl, 1 mM DTT buffer. Fractions corresponding to Ras-LUV
conjugated were used for further experiments.
Nucleotide exchange for 2'-/3'-O-(N'-Methylanthraniloyl) guanosine-5'-O-[(β,
γ- imidotriphosphate] (Mant-GppNHp) was performed as described in (145) with minor
modifications. In short, protein solution was dialyzed against nucleotide-exchange buffer
(50 mM TRIS, pH 8.0, 5 mM DTT, 200 mM (NH4)2SO4). Nucleotide exchange was
started by addition of Mant-GppNHp to a final molar ratio of 1:2 to protein. Shrimp
alkaline phosphatase (Fermentas) was added (10 units) to hydrolyze released GDP
molecules. Exchange was allowed to proceed for 2h at room temperature. Obtained RasGppNHp complex was dialyzed against 20 mM TRIS, pH 7.4, 1 mM DTT, 5 mM MgCl2
buffer and mixed with LUVs.
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Appendix A Supplementary Tables and Figures

Figure 4-2 pCR 2.1-TOPO vector map. Image from www.neb.com
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Figure 4-3 pET43.1a(+) vector map. Image from www.neb.com
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Figure 4-4 Sequence alignment of human N-Ras wild type protein (NCBI reference sequence
NM_002524.4) (top) and N-RasC118S-181C construct (bottom)
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Appendix B Lifetimes data
Table 4-7 Lifetimes of free mant nucleotides

Nucleotide

1

2

3

4

Avg

MantGDP

4.17

4.34

4.43

4.29

4.31

MantGppNHp

4.18

4.24

4.5

3.68

4.15

Life Times of Mant Fluorophore in Ras Lipoprotein Samples

Standard deviations and number of replicates for each measurement are given in
parentheses. FRET efficiency values and their standard deviation were calculated using
Eq. 1 and Eq. 2.
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Table 4-8 Life times of mant fluorophore in N-Ras lipoprotein samples loaded with mGDP and mGppNHp
associated with homogeneous and lipid raft membranes

N-Ras•mGDP

Lipid mix

Homogeneous LUVs

Raft LUVs

Temperature

5 oC

5 oC

16 oC

Lifetime F0, ns

7.47

5.28

5.16

(0.01, 4)

(0.05, 4)

(0.13, 2)

6.45

5.29

5.17

(0.04, 3)

(0.02, 4)

(0.15, 2)

0.137

-0.002

-0.002

(0.005)

(0.010)

(0.04)

Lifetime F, ns

FRET Efficiency

N-Ras•mGppNHp

Lipid mix

Homogeneous LUVs

Raft LUVs

Temperature

5 oC

5 oC

5 oC

preparation 1

preparation 2

8.92

7.87

6.56

(0.04, 4)

(0.15, 4)

(0.04, 2)

Lifetime F0, ns
(𝜏! )
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Lifetime F, ns
(𝜏!" )
FRET Efficiency

7.35

6.90

5.43

(0.05, 3)

(0.1, 4)

(0.07, 2)

0.176

0.123

0.172

(0.007)

(0.021)

(0.012)

Table 4-9 Life times of mant fluorophore in H-Ras “chimera” samples (H-Ras G-domain coupled
with N-Ras C-terminal lipopeptide) loaded with mGDP and mGppNHp associated with homogeneous and
lipid raft membranes

H-Ras_chimera•mGDP

Lipid mix

Homogeneous LUVs

Raft LUVs

Temperature

5 oC

5 oC

15 oC

Lifetime F0, ns

7.87

8.02

7.63

(0.01, 4)

(0.05, 4)

(0.13, 4)

6.76

5.55

5.87

(0.04, 4)

(0.02, 4)

(0.24, 4)

0.139

0.312

0.23

(0.005)

(0.010)

(0.04)

Lifetime F, ns

FRET Efficiency

H-Ras_chimera•mGppNHp
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Lipid mix

Homogeneous LUVs

Raft LUVs

Temperature

5 oC

5 oC

16oC

Lifetime F0, ns

7.99

8.49

8.39

(0.04, 4)

(0.14, 4)

(0.1, 4)

5.84

6.46

6.40

(0.09, 4)

(0.1, 4)

(0.24, 4)

0.27

0.24

0.24

(0.007)

(0.028)

(0.022)

(𝜏! )
Lifetime F, ns
(𝜏!" )
FRET Efficiency

Table 4-10 Life times of mant fluorophore in N-Ras lipoprotein samples loaded with mGDP and
mGppNHp associated with homogeneous and lipid raft membranes at high temperatures

N-Ras•mGDP

Lipid mix

Homogeneous LUVs

Raft LUVs

Temperature

37 oC

37 oC

Lifetime F0, ns

5.05 (0.12, 4)

3.63 (0.16, 4)

Lifetime F, ns

4.29 (0.15, 4)

3.57 (0.12, 4)

FRET Efficiency

0.15 (0.04)

0.02 (0.06)
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N-Ras•mGppNHp

Lipid mix

Homogeneous LUVs

Raft LUVs

Temperature

37 oC

37 oC

Lifetime F0, ns

3.94

3.97

(0.20, 4)

(0.13, 4)

3.95

3.86

(0.10, 3)

(0.15, 4)

0.01

0.03

(0.06)

(0.05)

(𝜏! )
Lifetime F, ns
(𝜏!" )
FRET Efficiency

Table 4-11 Life times of mant fluorophore in H-Ras chimera lipoprotein samples loaded with
mGDP and mGppNHp associated with homogeneous and lipid raft membranes at high temperatures

H-Ras•mGDP chimera

Lipid mix

Homogeneous LUVs

Temperature

10 oC

15 oC

20 oC

25 oC

30 oC

35 oC

40 oC

Lifetime F0, ns

7.33
(0.18, 4)

7.28
(0.20, 4

7.00
(0.28, 4

6.43
(0.06, 4

5.97
(0.09,
4

5.42
(0.16, 4

4.70 (0.30, 4
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Lifetime F, ns

6.55
(0.07, 4)

6.38
(0.09, 4

5.95
(0.12, 4

5.74
(0.16, 4

5.21
(0.44,
4

4.95
(0.15, 4

4.53 (0.15, 4

FRET Efficiency

0.11
(0.02)

0.12
(0.03)

0.1
(0.04)

0.11
(0.03)

0.13
(0.07)

0.09
(0.04)

0.03 (0.07)

H-Ras•mGDP chimera

Lipid mix

Raft LUVs

Temperature

10 oC

15 oC

20 oC

25 oC

30 oC

35 oC

40 oC

Lifetime F0, ns

7.38
(0.36, 4)

7.63
(0.17, 4

6.29
(0.29, 4

6.13
(0.10, 4

5.72
(0.59,
4

4.19
(0.70, 4

5.01 (0.70, 4

Lifetime F, ns

5.60
(0.38, 4)

5.87
(0.24, 4

5.44
(0.53, 4

4.71
(0.41, 4

5.31
(0.17,
4

4.66
(0.09, 4

-

FRET Efficiency

0.24
(0.06)

0.23
(0.04)

0.14
(0.09)

0.23
(0.07)

0.07
(0.10)

0.07
(0.19)

-

H-Ras• mGppNHp chimera

Lipid mix

Homogeneous LUVs

Temperature

10 oC

15 oC

20 oC

25 oC

30 oC

35 oC

40 oC

Lifetime F0, ns

7.57
(0.34, 4)

7.63
(0.13, 4

7.57
(0.31, 4

7.03
(0.09, 4

5.84
(0.06,
4

4.66
(0.33, 4

3.97 (0.11, 4
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Lifetime F, ns

5.74
(0.15, 4)

5.63
(0.12, 4

5.39
(0.12, 4

5.00
(0.18, 4

4.60
(0.18,
4

4.24
(0.13, 4

4.13 (0.04, 4

FRET Efficiency

0.24
(0.04)

0.26
(0.02)

0.29
(0.03)

0.29
(0.03)

0.21
(0.03)

0.09
(0.07)

0.04 (0.03)

H-Ras• mGppNHp chimera

Lipid mix

Raft LUVs

Temperature

10 oC

15 oC

20 oC

25 oC

30 oC

35 oC

40 oC

Lifetime F0, ns

7.57
(0.34, 4)

7.63
(0.13, 4

7.57
(0.31, 4

7.03
(0.09, 4

5.84
(0.06,
4

4.66
(0.33, 4

3.97 (0.11, 4

Lifetime F, ns

5.74
(0.15, 4)

5.63
(0.12, 4

5.39
(0.12, 4

5.00
(0.18, 4

4.60
(0.18,
3

4.24
(0.13, 3

4.13 (0.04.
4)

FRET Efficiency

0.24
(0.04)

0.26
(0.02)

0.29
(0.03)

0.29
(0.03)

0.21
(0.03)

0.09
(0.07)

0.04 (0.03)

Table 4-12 Life times of mant fluorophore in N-Ras lipoprotein samples loaded with mGDP associated
with lipid raft membranes at 5 oC in experiment with the nucleotide exchange of the protein attached to
membrane mimic

N-Ras•mGDP

Lipid mix

Raft LUVs

Temperature

5 oC before exchange

5 oC after exchange
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Lifetime F0, ns

Lifetime F, ns

FRET Efficiency

5.59

4.98

(0.16, 4)

(0.13, 4)

4.73

4.82

(0.08, 4)

(0.15, 4)

0.16

0.03

(0.05)

(0.08)
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Appendix C Contribution of Non-Specific Binding of Mant-Nucleotides
to LUV
In control experiments we used unlabeled homogenous LUVs. All conditions
(elution buffer, flow rate, sample volume) were kept identical to avoid artifacts and make
elution profiles comparable. The very first control sample contained a mixture of
homogenous LUVs with Mant-GDP nucleotide incubated overnight. As expected, MantGDP was eluted in a small molecules range. Only based on elution profile we cannot
exclude non-specific interaction of the nucleotide with LUV, therefore emission

1.5E+07

Full volume

3.0E+06

~500 kDa

4.0E+06

2.0E+06

1.0E+07
5.0E+06

1.0E+06

0.0E+00

0.0E+00

B 2.5E+07

5.0E+06

Relative intensity

Relative intensity

2.0E+07
1.5E+07

4.0E+06

3.0E+06

1.0E+07

2.0E+06

5.0E+06

1.0E+06

0.0E+00

0.0E+00
5.0E+06

2.0E+07

4.0E+06

Relative intensity

C 2.5E+07
Relative intensity

Void volume
>800 kDa

5.0E+06

Relative intensity

2.0E+07

Full volume

Relative intensity

2.5E+07

~500 kDa

A 3.0E+07

Void volume
>800 kDa

intensities of mant-group were compared (see below).
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Figure 4-7 Relative intensity of mant-signal in elution tubes for control injections. A) homogeneous LUVs
with Mant-GDP mixture; B) lipidated NRas-MantGDP; C) lipidated NRas-MantGDP with homogeneous
LUVs
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Second control sample represented by a lipidated N-Ras protein labeled with
Mant-GDP in absence of LUVs. The protein was eluted at a molecular weight of
approximately 500 kDa probably due to formation of aggregates.
Third control experiment represented an example reaction of lipidated protein
with LUV. As illustrated in Figure 4-7, the relative intensity of mant-group is shifted
towards high molecular weight suggesting the insertion of the lipidated protein into
membrane mimic. Comparing elution profiles B and C we cannot exclude absence of
lipidated Ras aggregates (500 kDa weight) in LUV-protein complex elution tubes,
therefore the contribution of that fraction was estimated below.

Appendix D Contribution of Non-Specific Binding of Mant-Nucleotides
to LUV
There is no evidence of specific interaction between the nucleotides and lipid
vesicles, due to the difference in polarity. Therefore, the “passive diffusion” is not the
case. However, if the molecule is small enough it may be “trapped” between the LUVs or
absorbed at the surface of LUV and therefore travel along them during the elution. To
estimate the contribution of this effect in our particular system both lipid mixtures were
examined: homogeneous and raft LUVs. In addition, the amount of non-specifically
bounded GDP and GppNHp mant-derivatives was estimated.
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Figure 4-8 Test for MantGDP association with homogeneous LUVs. The decays for the following samples
are pictured: A = F0 sample in absence of lipidated NRas (F0) t= 4.51ns (2.1%), B= F sample in absence of
lipidated NRas (F) t=6.3 ns (2.2%), C= F0 sample in presence of lipidated NRas (F0-NRas) t=7.5 ns
(27.1%), D = F sample in presence of lipidated NRas (F-NRas) t=6.5 ns (20.2%)
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Figure 4-9 Test for MantGDP association with raft LUVs. The decays for the following samples are
pictured: A = F0 t=4.9 ns (1.7%), B= F t=4.7 ns (1.6%), C= F0-NRas t=5.5 ns (17.8%), D = F-NRas t=5.5
ns (13.0%)
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Figure 4-10 Test for MantGppNHp association with homogeneous LUVs. The decays for the following
samples are pictured: A = F0 t=7.1 ns (2.4%), B= F t=5.6 ns (1.6%), C= F0-NRas t=8.9 ns (27.5%), D = FNRas t=7.3 ns (35.9%)
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Figure 4-11 Test for MantGppNHp association with raft LUVs. The decays for the following samples are
pictured: A = F0 t=5.3 ns (1.8%), B= F t=6.2 ns (1.2%), C= F0-NRas t=7.9 ns (10.1%), D = F-NRas t=6.9
ns (9.3%)

Conclusion: contribution of free Mant non-specifically bounded to LUVs is about
2%.
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Appendix E Contribution of the Lipidated Protein Unassociated with
LUVs
To estimate the percentage of mant signal from aggregated lipidated N-Ras nonassociated with LUVs the emission intensities of mant-group in tubes corresponding to
LUV fraction were compared. The contribution of scattering was taken into account by
subtraction of a blank buffer trace from both traces.
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Figure 4-12 Emission intensity of mant in “LUV” tubes in protein-LUV mixture and protein-only solution

The percentage of LUV-unassociated mant was calculated as
%unassociated mant = 60000 2.1𝐸 + 06 = 2.8%.
Conclusion: contribution of Mant unassociated with LUVs in Ras-LUV samples
is about 3%.
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Appendix F Calculation of the Surface Density for Lipidated Peptide
Added to LUVs
Using membrane size of 0.2 µm (known from an extruder membrane pore size),
we estimated the radius of LUV as 100 nm;
Therefore LUV surface area = 4𝜋𝑟 ! = 12.6 ∗ 10!   𝑛𝑚! = 0.126  𝜇𝑚!
Surface area of the lipid (avg) = 0.7 nm2 was estimated by Israelachvili and
Mitchel (146);
Number of surface lipid per LUV = 1.8 ∗ 10!   𝑙𝑖𝑝𝑖𝑑𝑠
Number of peptide molecules per LUV =
%  !"  !"!#$%"  !""#"
!""

∗ 𝑁𝑢𝑚𝑏𝑒𝑟  𝑜𝑓  𝑠𝑢𝑟𝑓𝑎𝑐𝑒  𝑙𝑖𝑝𝑖𝑑𝑠  𝑝𝑒𝑟  𝐿𝑈𝑉

Surface density =
% of peptide added

!"#$%&  !"  !"#$%&#$'  !"#  !"#
!"#$%&'  !"#!  !"  !"#

Number of molecules per

Surface density, molecules/

LUVs

μm2

0.1%

180

1400

0.5%

890

7100
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Appendix G Estimation of Number of Lipid Rafts per LUV
Size of the lipid raft is temperature-dependent. Pathak and London estimated that
size of lipid raft changes form ~150 Å at 10°C to less than 40 Å at 45°C (116). For our
calculations we used average radius of 100 Å (10 nm).
We assumed that the raft shape is circular and all have similar size, therefore
Area of lipid raft = π·r2 = π*(10)2 = 314 nm2;
Max possible number of rafts/LUV = LUV surface area / Area of raft = 400;
Rafts are expected to occupy approximately 10-40% of membrane (147), (148),
(149) resulting in 20 – 75 rafts per LUV.

Appendix H Estimation of the Length of Lipid Raft Boundary
Assuming that lipid raft has a circular shape, the length of the boundary for one
lipid raft is
C=2×𝜋×𝑟 =62.8 nm;
Using an average number of lipid rafts per LUV (50) we can estimate the total
lipid raft boundary per one LUV as follows:
Total raft boundary = 50*C = 3140 nm = 3 µm;
Taking into account that lipidated peptide has 7 amino acids (0.8 nm per one
amino acid), an estimated length of the peptidic part = 7 nm.
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In this simple estimate we assumed that lipids anchor the peptide at the boundary
and the peptide chain helps to shield hydrophobic mismatch of the thickness of raft and
disordered phase from solvent.
Dividing the length of the boundary for one lipid raft by peptide length: 62.8/7 =
maximum of 9 peptide molecules can possibly fit on lipid raft boundary;
0.1% peptide corresponds to 75 molecules; therefore 8 rafts (11% of the total
boundary) will be occupied;
0.5% peptide = 375 molecules, therefore 42 rafts (85% of the total boundary) will
be occupied.

Appendix F Calculation of the Protein Surface Density for Ras-LUV
Complex
Calculation of total number of lipids per LUV followed Hutchinson et al. (150):
𝑁𝑡𝑜𝑡𝑎𝑙 =   

4𝜋(𝑑 2)! + 4𝜋(𝑑 2 − ℎ)!
𝑎

where d is a diameter of LUV (known from an extruder membrane pore size), h is a
thickness of the bilayer (~ 5nm), a is the lipid head group area (a for POPC is ~0.71 nm2
(146, 151).
If d = 200 nm, then Ntot = 3.4 × 105 lipids;
Total number of LUVs per milliliter of liposome solution was calculated using the
following equation:
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𝑁𝑙𝑖𝑝𝑜 =

𝑀𝑙𝑖𝑝𝑖𝑑 ×𝑁𝑎
𝑁𝑡𝑜𝑡 ×1000

	
  

where Na is the Avogado Number (6.02×1023), Mlipid is molar concentration of the lipid,
Ntot is total number of lipids per LUV;
Molar concentration of lipid was determined using Rhod-DOPE absorbance in
eluted fractions (ARhod-DOPE = 0.054, CRhod-DOPE = 0.054/88,000 = 0.6 µM).
Total lipid concentration = 0.6 µM / 0.02 = 30 µM;
Nlipo = 5.4 ×1013 liposomes/LUV
Number of lipidated Ras molecules was estimated using Bradford assay:
Concentration measured,
μg/ml

Concentration,
mol/L

Surface density,
mol/μm2,

homogeneous LUV sample

9 ±2

4.5 ×10-7

40,000

raft LUV sample

3±2

1.5 ×10-7

13,000
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Appendix G Sequence alignment of H- and N-Ras isoforms

Catalytic domain represented by residues 1-166 and mostly conserved. Hypervariable
region, which closely interact with membrane is different between all three isoforms
(residues 167-188/189, black box). Sequence corresponding to helix α4 (black box,
residues 121-137) is the second least conserved extended sequence stretch after the HVR.

